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Abstract: This paper reviews the occurrence of antimicrobial resistance (AMR) in insects, rodents, and
pets. Insects (e.g., houseflies, cockroaches), rodents (rats, mice), and pets (dogs, cats) act as reservoirs
of AMR for first-line and last-resort antimicrobial agents. AMR proliferates in insects, rodents, and
pets, and their skin and gut systems. Subsequently, insects, rodents, and pets act as vectors that
disseminate AMR to humans via direct contact, human food contamination, and horizontal gene
transfer. Thus, insects, rodents, and pets might act as sentinels or bioindicators of AMR. Human
health risks are discussed, including those unique to low-income countries. Current evidence on
human health risks is largely inferential and based on qualitative data, but comprehensive statistics
based on quantitative microbial risk assessment (QMRA) are still lacking. Hence, tracing human
health risks of AMR to insects, rodents, and pets, remains a challenge. To safeguard human health,
mitigation measures are proposed, based on the one-health approach. Future research should include
human health risk analysis using QMRA, and the application of in-silico techniques, genomics,
network analysis, and ’big data’ analytical tools to understand the role of household insects, rodents,
and pets in the persistence, circulation, and health risks of AMR.
Keywords: antimicrobial-resistant microorganisms; antimicrobial resistance genes; companion ani-
mals; human exposure pathways; human health risks; quantitative microbial risk assessment
1. Introduction
Antimicrobial resistance (AMR) is an emerging global health concern to both animals
and humans. In general, AMR is a collective term referring to the capacity of microorgan-
isms (often pathogenic) to develop physical or biochemical mechanisms and processes that
render antimicrobial agents ineffective, including antibiotics [1]. Compared to other forms
of AMR, antibiotic resistance is most broadly covered by the literature due to its prominence
in human and animal health. In this paper, the term antimicrobial resistance is used to refer
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to both antibiotic resistance and other forms of antimicrobial resistance. Global estimates
show that approximately 700,000 deaths occur each year due to antimicrobial-resistant
bacterial infections [2]. For example, in 2016 alone, approximately 126,000 people died
from extensively drug-resistant and multi-drug-resistant tuberculosis [3,4]. This figure is
potentially higher if one considers other antimicrobial-resistant human infections caused by
the ESKAPE pathogens [5,6]. ESKAPE refers to a group of multi-drug-resistant pathogens,
including—(1) Enterococcus faecium, (2) Staphylococcus aureus, (3) Klebsiella pneumoniae, (4)
Acinetobacter baumannii, (5) Pseudomonas aeruginosa, and (6) Enterobacter spp.) [7]. Recently,
the list was extended to include; (1) Clostridium difficile, (2) Proteus spp., and (3) pathogenic
Escherichia coli [5]. Due to its public and animal health significance, AMR attracted signif-
icant global research and public attention [6,7]. Hence, a considerable body of evidence
exists on the subject.
The existing literature on AMR, including review papers, focused on the following
aspects, among several others—(1) human infections, including nosocomial ones or those
associated with healthcare facilities [7,8], (2) occurrence in animal production systems [9],
and (3) occurrence, fate, and health risks of AMR in various environmental compart-
ments [10]. To date, AMR was reported in the following environmental compartments—(1)
human-impacted soils [11], (2) industrial and municipal wastewater systems [12,13], (3)
surface water and groundwater systems, including drinking water systems [14], and (4)
ambient environments including particulate matter and aerosols [15,16]. A wide range
of antimicrobial-resistant microorganisms and antimicrobial resistance genes of human
health concern were detected, including the ESKAPE pathogens [5,6,10].
An increasing body of recent evidence shows that antimicrobial resistance occurs in
insects, wildlife, including rodents and birds, and even companion animals or pets [17,18].
Several insects, including edible ones and those associated with household settings such as
cockroaches, houseflies, ants, and mosquitoes, were reported to harbor AMR [19,20]. AMR
was also reported in household rodents, including mice and rats [21]. In other studies,
AMR was reported in common companion animals/pets such as domesticated and stray
dogs and cats, as well as wild animals that are often used as pets, such as raccoons [22,23].
The occurrence of AMR in household insects, rodents, and companion animals/pets is a
major human health concern. This is because such insects, rodents, and animals might
transmit AMR to humans via direct contact or food contamination. However, compared to
other compartments such as AMR in humans, and industrial and municipal wastewater
systems, comprehensive reviews on AMR in household and edible insects and rodents
are still lacking. Barring a few exceptions [24,25], comprehensive reviews on AMR in
companion animals/pets are still limited. The few available review papers are mostly
limited to developed countries such as the European Community [24]. Thus, AMR in
companion animals in developing countries received limited attention. Yet, developing
countries have several unique risk factors, including a putatively high number of stray
animals and weak and poorly enforced animal and human health regulations.
Therefore, the present review posits that (1) insects and rodents, including edible ones
and those associated with household settings and pets, harbor and act as reservoirs of a
diverse range of antimicrobial-resistant microorganisms and resistance genes of human
health concern; (2) the animal compartments comprise insects, rodents, and pets, which act
as transmission vectors and sentinels or bioindicators of AMR; and (3) the persistence and
dissemination of AMR via insects, rodents, and companion, pose significant human expo-
sure and health risks. To address these hypotheses, the source-pathway-receptor-impact
framework was used to track the occurrence and circulation of AMR in the environment–
animal (insects, rodents, pets)–human interface.
Figure 1 presents a summary of the focus of the present paper. Specifically, the
various environmental reservoirs of AMR or resistomes that include solid waste and
wastewater systems, animal and human health care facilities, livestock production systems,
and wildlife, among others. The insect, rodent, and pet resistomes or reservoirs are also
shown including the exchange of AMR among them, via various processes, including
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horizontal gene transfer. These reservoirs or resistomes act as both sources and sinks
of AMR, resulting in complex circulation of AMR among the various compartments.
Human exposure to AMR via ingestion of contaminated food, inhalation of contaminated
particulate matter and ambient air, and direct contact and bites is also shown. Moreover,
the occurrence of AMR in pets, rodents, and insects make them ideal sentinels for AMR
surveillance. Finally, the human health risks, and future research needs are summarized.
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2. Antimicrobial Resistance
2.1. Nature
AMR is classified into two groups—intrinsic or acquired. While intrinsic AMR results
from the ability of the microorganism to survive in the presence of an antimicrobial agent
because of an inherent property of the microorganism, acquired AMR emanates either
from gene mutation or by the microorganism acquiring extra gene coding for a resistance
mechanism [26]. Although antibiotic resistance is commonly studied, others such as
antifungal resistance [27,28], antiparasitic resistance [29], and antiviral resistance [30,31]
were also documented.
As antimicrobials are commonly used in the management of microbial infections
in veterinary and human medicine, and also as growth promoters in livestock, ABR is
exacerbated in natural and man-made environments and consequently attracts relatively
wider research attention [32–34]. Such extensive use and misuse of antimicrobial agents
put bacteria under selection pressure to develop resistance [26,29].
The interfaces among humans, animals, and the environment are hotspots for the
exchange of antimicrobial-resistant microorganisms and their resistance genes [35]. Pre-
vious studies that addressed the impacts of agricultural pollution on AMR showed that
interaction with livestock can result in the transmission of antimicrobial resistance to wild
animals [36]. The common pathogen exposure pathways of clinically significant AMR are
antibiotic usage in humans and livestock, while data on the fate of AMR outside these
hosts, is scarce. It is, however, evident that focusing on these compartments only results in
an inadequate understanding of the epidemiology of AMR [35]. In this regard, a number
of surveillance strategies were used to monitor the occurrence and patterns of AMR in
animals and humans [37]. For the human host, these strategies are, however, limited by
high costs, ethical requirements, and challenges in sampling protocols. Consequently, a
range of sentinels, including houseflies, rodents, shrews, field mice, and chickens, were
used for AMR surveillance [35–41].
2.2. Mechanisms of AMR
Antimicrobials are continuously discharged into the environment due to their inten-
sive usage, resulting in the emergence of antimicrobial resistance [42,43]. Microorganisms,
including bacteria, can readily adapt and develop resistance against antibiotics, releas-
ing antimicrobial resistance genes (ARGs) into the environment [43]. Through genetic
transformation, ARGs are transmitted to environmental microorganisms and pathogens,
exacerbating environmental, and human health risks [32]. The development of antimi-
crobial resistance in microorganisms depends on two key factors, namely, the existence
of ARGs and the selective pressure exerted by antibiotic usage [26]. Recently, antibiotic
management of common infectious diseases showed diminished effectiveness, owing to
prolific use, increased microbial resistance, and the propagation of ARGs via transposable
elements and plasmids among microbial communities [43].
Apart from occurrence in livestock and wild animals via interactions through shared
environments, AMR is detected in cockroaches [44–46], wild mammals such as riverbank
voles [36], birds [35], and houseflies [47]. The transmission pathways from these animals
to humans are gaining research interest. For instance, studies showed that Yersinia pestis,
which causes plague, can be transferred from one rodent to another through flea bites [48].
This can cause bubonic plague via rodent-to-human transfer by infected fleas from cats,
rats, or wild rodents. Further human-to-human transmission via body fluids can cause
the pneumonic plague. The role of wild small mammals as potential reservoirs of AMR
is poorly understood, and further research is needed [41]. Another study reported that
houseflies carry antibiotic-resistant enterococci, with the potential to horizontally transfer
ARGs to other microorganisms [38].
The main mechanisms for the development of antimicrobial resistance related to
drug usage are (1) new opportunistic pathogenic microbes emerge, which are usually
antimicrobial-resistant; (2) new acquired resistance mechanisms emerge; (3) gene mutation
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in the host chromosome or plasmid-borne occurs; and (4) due to the dispersion of old
resistance genes into new host microorganisms [49]. A more detailed discussion of the
occurrence of AMR and its transfer between the environment and humans is provided in
earlier reviews [26,50,51]. The problems associated with AMR are additionally convoluted
by horizontal gene transfer (HGT), the process through which adaptive genes are exchanged
among microorganisms [26]. Incidentally, HGT is important for the evolution of species [49].
HGT in microorganisms proceeds via three key mechanisms—(1) natural transformation,
which involves the uptake and integration of DNA derived from the extracellular media;
(2) conjugation, a common mechanism for DNA transfer; and (3) transduction, which is
bacteriophage facilitated transfer [26].
Acquired resistance is mainly transferred via HGT of environmental or microbial
ARGs, and this is facilitated by mobile genetic elements (MGEs) [42]. While intrinsic
resistance does not undergo horizontal transfer and is benign in non-pathogenic microor-
ganisms, acquired resistance occurs in some microbial strains, which are often vulnerable to
the antimicrobial agent under investigation, and might be horizontally transferred among
microorganisms [26]. As a result, several previous studies profiled ARGs and MGEs, such
as bacteriophages, insertion sequences, integrons, plasmids, and transposons [26,42,52].
The genes that confer AMR can disperse rapidly, passing on to microorganisms not initially
exposed to the selective pressure, thus spreading throughout microbial populations [36].
For example, apart from clinically significant microbial species, many researchers suspect
that commensal bacteria such as lactic acid bacteria, enterococci, and streptococci could
be reservoirs of ARGs, comparable to those in human pathogens [26,53,54]. The signifi-
cant health risk related to these bacteria is their propensity to transfer resistance genes to
pathogenic microorganisms.
The genetic modifications in acquired resistance alter the defenses of the microor-
ganisms through several pathways. These include (1) altering the target receptor of the
antimicrobial agent, (2) altering membrane permeability to antimicrobial agents, (3) en-
zymic inactivation of the antimicrobial agent, (4) active transportation of the antimicrobial
agent via efflux pumps, or (5) by directing metabolic routes to avoid disruption [26]. It is
likely that AMR evolved way before the usage of antibiotics for clinical purposes. These
resistance genes might arise from the antimicrobial producers that possess resistance genes
for self-protection from the antimicrobial products. A further potential source of resis-
tance genes is probably genes whose products participate in the metabolic processes of
the microorganisms. Such genes might gradually mutate, which alters the substrate from
substrates of biodegradative or biosynthetic routes to antibiotics [26].
2.3. Conventional and Emerging Analytical Methods for Antimicrobial Resistance
Following the capture of the host insects or animals such as cockroaches and flies,
the microorganisms can be isolated using classical methods (e.g., washing with saline
water) and then subjected to standard protocols for antimicrobial susceptibility test-
ing [32,33,39,40,55–57]. To identify antibiotic susceptible microorganisms or ARB in a
sample, the minimum inhibitory concentrations (MIC) of antibiotics to particular bacteria
are predefined [58]. The MIC values are for the defined bacterial species, but they are not
defined for many environmental bacteria that do not often grow on culture media. There-
fore, these methods are biased in that they focus on selected bacteria based on the isolation
media used, while other non-targeted bacteria might also be carrying resistance but are
not detected. Additionally, this approach is mainly phenotypic and does not give data
on ARGs responsible for the observed resistance. Generally, standardizing culture-based
methods provide a simple and inexpensive data comparison, especially in nutrient-starved
host matrices.
Cultural methods still dominate studies on AMR. There is a need to improve on
methods and implore advanced technologies, such as the sequencing of the whole genome
based on antimicrobial-resistant microbial isolates. This could be helpful in providing
critical information, e.g., for identifying shared microbial strains, antibiotic resistance
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genes, and mobile genetic elements [59,60]. Using approaches such as metagenomics in
determining the abundance of antimicrobial-resistant microorganisms, resistance genes,
and mobile genetic elements, e.g., in the gut of rodents, could provide a clearer and better
picture of the routes through which AMR spreads or direction of the transmissions [59,61].
To quantify AMR, it is essential to understand the advantages and disadvantages
of conventional culture-based methods and molecular-based methods. Culture-based
methods require immediate sample treatment and are limited to particular microbial
strains and bacteria that can be cultured on synthetic media [39]. This approach thus
excludes bacteria that are in a viable but non-culturable form, or ARG carrying non-target
microorganisms that do not grow on the selective media. This can result in false-negative
results. The commonly used molecular-based method to detect ARGs is the quantitative
polymerase chain reaction (qPCR) method, which is based on the intensification of the
nucleic acid [36]. This method involves recovering the DNA of microorganisms from total
DNA samples and amplifying ARGs, following standard procedures. Particular microbial
genes are determined using predefined primers [37]. The qPCR technique is highly specific,
rapid, and has a high accuracy [6,43]. Consequently, through the application of qPCR,
the total ARGs in all strains of microorganisms, bacteriophages, mobile DNA fragments
such as integrons, plasmids, and transposons, and environmental DNA (eDNA) could
be detected. Furthermore, sample processing with propidium monoazide endows qPCR
with capabilities to distinguish DNA derived from living cells, as opposed to DNA from
dead cells, phages, or fragments of eDNA. Hence, potential ABR donors of ARGs could
be enumerated. However, on its own, PCR does not detect the microorganisms carrying
the specific resistance genes and infer their significance to human health. Moreover, the
method is confined to known genes, rendering it inconclusive on the total resistance
to a particular antimicrobial agent. Thus, data for determining a single resistance gene
might be inadequate to quantify the actual resistance to the particular antibiotic present.
In this regard, highly parallel qPCR analyses, ChipSeq, microarrays, or next-generation
sequencing could potentially solve this problem, but they are expensive and usually require
high expertise [33,39].
In addition to qPCR, a range of modern techniques are used to detect and quantify
ARB. For example, following an extraction, gel electrophoresis was used to determine the
quality of the DNA [42]. A similar study used pulsed-field gel electrophoresis to identify
DNA from streptomycin-resistant E. coli and Yersinia strains [48]. Yet another study deter-
mined AMR staphylococci using MALDI-TOF [41]. The application of genomic methods
in understanding AMR attracted research interest. Extensive genomic studies employing
high-throughput sequencing data represent powerful novel approaches that rapidly detect
and respond to genetic transformations associated with AMR [62]. Nevertheless, these
studies lack mechanistic details. In this regard, computational techniques can speedily and
cost-effectively assess the impact of mutations on the function of proteins and their evolu-
tion. Recently, methods that depend on mathematical modeling and artificial intelligence
were used to predict the occurrence and fate of AMR without the requirement of laborious,
expensive, and sometimes inconvenient in-situ analyses [63]. In addition, big data analytics
such as artificial neural networks and artificial intelligence already showed great promise
in microbiological diagnostic testing and assisting in clinical decision making [64,65]. The
main strength of these techniques is their capability to generate and handle large amounts
of data and predict the prevalence of AMR from historical data [63,65]. They can, thus, be
used to select the best intervention strategies or experimental conditions that generate data
for developing preventive and remediation approaches. With the advancement in technol-
ogy, new analytical methods are expected to emerge. These would cover non-intrusive
sampling, minimal sample preparation, and rapid analysis, and are expected to be faster,
simpler, and more accurate in the near future.
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3. The Role of Insects, Rodents, and Pets in AMR Persistence and Transmission
3.1. Insects
Several insects, including those associated with household settings, are reported to
harbor AMR (Table 1 and Table S1). To date, AMR in insects was reported in several
countries (Figure 2). Table 1 shows that insects harbor microorganisms possessing genes
conferring resistance to a wide range of antimicrobials, including ampicillin, tetracycline,
streptomycin, ciprofloxacin, gentamicin, sulfamethoxazole, chloramphenicol, penicillin,
and kanamycin. Almost all studies use physical traps, sometimes in combination with
insecticides, to randomly capture insects present at a location. Houseflies are the most
commonly occurring insect in most environments and exist in close association with
humans [37,47,66,67]. It is unsurprising, therefore, that houseflies are the most widely
studied. These studies use traps that are inefficient at catching all kinds of available insects,
which might explain why only a few, most prevalent insects at most sites are the ones
studied. For instance, sweeping with a broom was used to catch houseflies in one study [47],
while sweep nets were used in another study resulting in a catch of just three types of
insects; houseflies (Musca domestica), false stable flies (Muscina stabulans), and stable flies
(Stomoxys calcitrans) [67]. However, in the same study, it was unclear whether or not an
insecticide was used prior to sweeping.
Insects such as houseflies and cockroaches can move unrestricted between differ-
ent environmental compartments, allowing them to easily spread antimicrobial-resistant
pathogens. This high dispersal ability of insects is set to promote the occurrence and
persistence of antimicrobial resistance in humans, emanating in anthropogenic activities
in other sectors such as agriculture. For instance, houseflies and cockroaches successfully
transmitted antimicrobial-resistant bacteria obtained in pig manure from two commercial
confined swine farms [39,51]. In addition, several antimicrobial resistance organisms were
isolated from the products of commercial livestock and linked to human health resistance
to certain drugs [51,68,69]. In Zimbabwe, chickens were reported to harbor antimicrobial-
resistant E. coli, exhibiting multi-drug resistance to several antibiotics, including cloxacillin,
tetracycline, ampicillin, neomycin, and bacitracin [40]. The study did not investigate the
transmission of AMR to humans, other animals, or insects. These findings are critical
for decision-and policy-making, particularly in developing countries, where unregulated
housing developments close to agricultural facilities are common. Intensive livestock
production systems, especially of poultry, pigs, and dairy cattle confined in small areas,
involve intensive use of veterinary drugs and antimicrobials in animal feeds. This is a
public health concern, as the antimicrobial-resistant pathogens can be transferred from the
livestock to humans through meat and eggs and via vectors such as insects and rodents.
In the study by Saidi et al. [40], the liver, egg yolk, and heart of the chickens contained
antimicrobial-resistant bacteria. In addition, flies and cockroaches can transport the bacteria
from the poultry runs to residential homes due to their unrestricted movements.
The alarming rise in antimicrobial resistance, even to the last-resort antibiotics, is
an unprecedented challenge to public health, as it limits treatment options of microbial
infections. Thus, the World Health Organization has called for a “One Health” approach
to find effective solutions to address this challenge [70]. While this approach advocates
for collaborative efforts to address this problem in humans, animals, and the environment,
specific components might need to be given attention as they might not always be easily
classified into the One Health compartment. Examples of such compartments are insects
and rodents. Insects and rodents harbor numerous microorganisms, including antibiotic-
resistant pathogens, as evidenced in the numerous research findings reported globally,
involving different insects sampled from different sources, including households (Figure 1;
Table S1). Some studies reported resistance to last-resort antibiotics like colistin, in bacteria
from flies [71,72]. Similarly, the presence of Extended Spectrum Beta-Lactamase-producing
microorganisms was reported in recent studies [73]. Understanding how insects acquire
these bacteria and transmit them to humans and other animals is crucial to establish effec-
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tive intervention measures, to prevent the spread of AMR through these often neglected
yet important organisms.
Figure 2. Countries (shaded) that reported AMR in insects between 2010–2020. The search was based on PubMed Central
and Google Scholar databases.
Most insects prefer damp areas, and dead and decaying matter, including sewers, car-
casses, human and animal fecal matter, and garbage, among others. Through frequenting
such unsanitary environments, the insects come into contact with pathogens and subse-
quently transmit them to other compartments, including humans. The exoskeleton and
alimentary canal (or gut) of the studied insects acted as reservoirs for antimicrobial-resistant
microbiota, antimicrobial resistance genes, and mobile genetic elements. Besides the ex-
oskeleton and feces, the gut, saliva, or vomit through regurgitation is another additional
reservoir and source for transmission [74]. When feeding, houseflies regurgitate liquid
from the stomach to dissolve food, then use their sponging mouthparts to suck it up. While
houseflies leave fecal spots, cockroaches also leave behind fecal droppings as they feed and
move around. About 98% of cockroaches collected in one study had bacteria in both their
external surfaces and alimentary canal, though significantly higher for the latter [44]. Using
houseflies, the total number of non-fecal-related oocysts dislodged from their exoskeleton
was 463, compared to 564 fecal-related oocysts [75]. During the experimental period, the
number of non-fecal-related oocysts significantly decreased from 267 to 14 from day 3 to
11, while fecal-related oocysts significantly increased from day 3 to 11 [75]. It was also
demonstrated that P. aeruginosa could multiply in the gut of cockroaches and be excreted for
up to 114 days. These findings show that, in addition to being AMR vectors, houseflies and
cockroaches are also amplifiers of antimicrobial-resistant pathogens and their associated
resistance genes. However, more work needs to be done to ascertain this phenomenon in
detail and confirm its occurrence in other insects and rodents. Pathogens in the guts of
houseflies and blow-flies were three times greater than on their body surfaces [66]. These
findings confirm that the exoskeleton or external surface of insects and the feces or gut are
reservoirs and routes of transmission. The contribution of the exoskeleton is, albeit inferior
to that of the gut. Insects have hairs and bristles, as well as a structure called pulvillus with
surface adhesive—though on varying parts of their bodies [74,76]. These body parts facili-
tate the adhesion of substances onto the insect and allow the insect to attach to surfaces as
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it climbs or walks. Thus, pathogens can adhere to insects, and pathogens attached to these
hairs, bristles, or pulvilli might not get dismantled easily, resulting in lower transmission
via the external surface compared to the feces [75]. It should be emphasized that more
work is needed, which incorporates individual fly assessments to ascertain the location
of the pathogens on the insect, as this might assist in disease monitoring, risk assessment,
and control, among other epidemiological implications.
In one study, several types of flies (namely, secondary screwworm, Cochliomyia macel-
laria (prevalence-2%), the red-tailed flesh fly, Sarcophaga haemorrhoidalis (prevalence-2%),
and the black garbage fly, Ophyra leucostoma (prevalence-1%)) were sampled using the
sweep nets, but the analysis of their guts revealed almost non-existence of the tested
pathogens [66]. It also follows that only those insects that are widely associated with
disease transmission receive much research attention. These insects include houseflies,
cockroaches, and to a less extent, blow-flies. A few earlier review papers investigated the
role of houseflies in the transmission of antimicrobial resistance, but these were limited
to only antibiotic resistance and bacteria [51,74]. This present review focuses on all kinds
of insects and how they act as possible sources of resistant pathogens and ARGs in the
environment.
3.1.1. How Insects Acquire Resistant Bacteria
Insects can acquire antimicrobial-resistant microorganisms through various mech-
anisms. One such mechanism is the physical contact of the flies with polluted envi-
ronments containing antimicrobial-resistant microorganisms. For example, flies have a
hairy proboscis that produces sticky substances, allowing bacteria to attach to these body
parts [72]. Hairs on other body parts of flies (e.g., wings, legs) also facilitate the attachment
of antimicrobial-resistant microorganisms on their exoskeletons [77].
Insects can also acquire resistant microorganisms by feeding on foods contaminated
by these organisms. In an experiment, sterile cockroaches were fed with Salmonella-
contaminated foods, and the bacterium was isolated in different insect parts, including their
guts [78]. This ability of insects to feed on bacteria is exploited in biotechnology. For exam-
ple, the shift to natural manure led to the search for novel methods to treat manure before
application on farms. Many scientists recently reported using housefly larvae to attenuate
the antibiotic resistome in swine manure, a practice known as vermicomposting [79,80].
Wang et al. [80] reported that the population of tetracycline-resistant bacteria and their
associated tet (M, O, K, W) genes were significantly reduced in manure exposed to larvae
of the housefly. Although proven to be a promising biotechnology approach for reducing
antimicrobial resistance in manure, the bioaccumulation of antimicrobial resistance genes
and antimicrobial-resistant microorganisms in the flies is not given full attention. For
example, one study demonstrated that flies could internalize ARB throughout their life
cycle [81]. Thus, flies that emerge from such manure treatment practices could be potential
environmental reservoirs of ARB and ARGs, and subsequent vehicles for transmission
to humans, as it was shown that the housefly could travel as far as 7 km from poultry
farms [82].
Apart from directly feeding on food infected with ARB, normal flora of insects can
acquire resistance due to exposure to sub-lethal doses of antibiotics. For example, the use of
antibiotics in agriculture favored the exposure of many insects to these chemotherapeutic
agents, causing selective pressure on the insects’ gut microbiome. A well-known example
is the historical use of tetracycline in honeybees, which contributed to the development of
AMR in the bees’ gut microbiome [83]. Bacteria in insects can also acquire resistance when
these insects feed on specific plants that produce secondary metabolites with antibacterial
properties [84].
3.1.2. Insects as Reservoirs of Antimicrobial Resistance
Insects are known to invade and inhabit human foods, whether accidentally or inten-
tionally [85]. Some of these insects occur in habitats such as cracks and crevices within
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human homes [86]. Their presence in these places could have direct and indirect impacts
on human health. Many of these insects were reported to carry large numbers of diverse
microorganisms, including antibiotic-resistant ones. For example, in a study conducted in
a hospital in the United Kingdom, 82 bacterial strains were isolated from 19,937 different
fly species, and 68 of these were resistant to at least one of a set of 11 antibiotics while
11 strains were multi-drug-resistant [87]. The authors also reported bacterial counts as high
as 1010 colony forming units (CFU) per fly per mL.
Another study demonstrated that the gut of cockroaches represented a favorable
environment for the horizontal transfer of resistance genes between E. coli and other Enter-
obacteriaceae [88]. The same authors reported the transfer of resistance genes for ampicillin,
kanamycin, and tetracycline resistance in the insect’s intestines, thus recognizing cock-
roaches as potential reservoirs for the transfer of antibiotic-resistant bacteria. Yet another
study reported that houseflies were more than just mechanical vectors of AMR, but that
their intestines were a favorable environment for the transfer of ARGs to closely related
bacterial species [89]. The same authors reported that plasmid-borne cephalosporin resis-
tance genes were successfully transferred from E. coli to Acinetobacter sp. and Pseudomonas
fluorescence within the intestines of the flies. In a similar study, one-day-old houseflies were
fed with an antibiotic-resistant E. coli suspension, followed up to the next-generation [81].
The results showed that, apart from horizontal gene transfer within the fly, vertical transfer
was possible from one fly generation to another. In addition, the antimicrobial-resistant
bacteria were transferred to the eggs, larvae, pupae, and finally, the next-generation of
adult flies. Related studies reporting on horizontal gene transfer within the fly intestine
include the transfer of tetracycline genes among E. faecalis [90] and ampicillin-rifampicin
resistance transfer in E. coli [91].
Most insects captured and studied in most studies harbored antimicrobial-resistant
microbiota, ARGs, and MGEs [39,51,58]. The feces of the German cockroach (Blattella
germanica) and the digestive tract of houseflies were dominated by the multi-drug-resistant
bacteria, E. faecalis, along with the associated ARGs; tet(M), erm(B), gelE, esp, asa1, and the
Tn916/1545 transposon family obtained from swine farm manure [39]. Metagenomic analy-
sis revealed the simultaneous occurrence of pathogens, with ARGs and MGEs responsible
for horizontal gene transfer among bacteria in sludge samples of domestic wastewater in
Beijing, China [42]. Hence, insects that breed or feed or inhabit in such media as wastewater
or fecal material potentially carry the ARMs, ARGs, and MGEs along with them, impart
resistance to other microbes, as well as pass them on to humans, as they get in contact with
human skin and foodstuffs with their pathogen-laden saliva, exoskeleton, and fecal matter.
3.1.3. Insects as Vectors of AMR
The antimicrobial-resistant microorganisms carried on insects can be transmitted to
other insects and surfaces through different mechanisms. This transmission could have
severe public health implications. For example, a study conducted in South Africa reported
no differences in the bacteria isolated from cockroaches and patients in a hospital, during
an outbreak [92]. The authors concluded that cockroaches played a role in spreading
ESBL-producing K. pneumoniae in neonates within the studied hospital environment. This
conclusion was further strengthened when the number of new cases dropped significantly,
following intervention measures that resulted in eliminating the insects. Similarly, a
direct correlation was observed between the density of flies and the incidence of Shigella
infections in Bangladesh [93].
On the one hand, the ARB occurring on the outside layers of the insects, usually on
the legs and mouth, are transferred mechanically as the insects interact with different
types of surfaces and other insects. The mechanical transfer was reported in a study
that demonstrated that E. coli carried on the outer surfaces of flies was transferred to
different food types, including steak, milk, and potato salad [94]. On the other hand, the
internally-borne bacteria are transmitted through the insects’ feces, saliva during feeding
(regurgitation), or during the decay of dead insects [95,96]. In one study, houseflies were
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fed with fluorescent-labeled bacteria to investigate the migration of the bacteria in the
fly and study the possibility of transmission to other surfaces following ingestion [97].
It was observed that the fly’s crop presented a favorable environment for their thriving
and that the bacteria were present in water and food with which the flies had contact.
A study on cockroaches fed with an antibiotic-resistant strain of Salmonella reported the
ARB were transferred to nymph grown under sterile conditions [78]. It was observed that
both the Salmonella-fed cockroaches and the sterile ones harbored the test organism. This
study demonstrated that cockroaches (and other insects) could pick up bacteria (including
antimicrobial-resistant ones) from dirty environments and transfer them to clean environ-
ments and other insects. Allen [98] demonstrated the transfer of ARB from cockroaches
through defecation, using a laboratory experiment. In this study, cockroaches were fed
with human saliva containing Mycobacterium tuberculosis. The feces from the insects were
then collected and examined for the presence of the bacilli, and it was observed that the
bacterium was present in the insect’s feces for up to eight weeks, at room temperatures.
Using metagenomics, it was also demonstrated that the intestinal microbiome of cock-
roaches shared up to 90% similarity with that of the insects’ feces [99], further supporting
the potential of the insects as vectors for ARB. Conversely, AMR can be transmitted from
humans to animals, and from insects such as flies and cockroaches, from human hospitals
to animals. This complex and continuous exchange of AMR among the various compart-
ments or resistomes, which also applies to rodents and pets, underpins the ‘one world, one
health’ concept.
In addition to sharing their habitats with humans, some insects serve as food, due to
their high energy content. With a global shift to insects as alternative protein sources [100],
humans could get infected by eating inadequately cooked or raw insects. Thus, as described
for the transfer of resistant bacteria by insects to different surfaces and food, the same
mechanisms apply to the transfer of these bacteria to humans. Humans can get infected
with insect-borne ARB by ingesting insects. In addition, transmission might also occur
indirectly through contact with surfaces and kitchen utensils infected by these flies [101],
or through consumption of food or drinking water contaminated by these insects.
One laboratory study used nalidixic acid-resistant Salmonella spp. to ascertain whether
cockroaches could acquire ARB from contaminated sites and subsequently transmit these
to clean surfaces, water, and other cockroaches [102]. The results showed that the infected
cockroaches successfully transferred the resistant bacterium into water, table eggs (whole
uncracked egg surfaces), and other insects, with contamination occurring up to four days
following the start of the experiments. For biting insects like spiders [103], mosquitoes [104],
and bed bugs [105], the transfer of ARB to humans could occur through insect bites.
Earlier literature suggests that effective management for the control of the spread of
AMR through insects should target the reduction of insect populations [39]. Given that flies,
for example, can travel for long distances, animal production facilities must be situated far
away from human settlements. However, rapid industrial development in many developed
countries led to intensive animal farming in residential areas [106]. Therefore, measures
that aim to prevent the escape of flies from these settings should be put in place. This could
be done using fly bait areas that would attract the insects and prevent them from moving
out of the farms. The possibility of AMR transfer by insects from animal farms to humans
is a major challenge for most low- and middle-income countries, especially in sub-Saharan
Africa, where animal farms are usually located in proximity to houses [107]. Such closeness
would allow for the easy movement of insects between the farms and households, thus
exposing humans to ARB.
Despite the numerous studies on the role of insects as reservoirs and vectors of AMR
transmission, a number of gaps exist. Most studies were carried out on houseflies and
cockroaches, and only a few studies looked at other insects such as spiders, butterflies,
mosquitoes, moths, for example, with which humans regularly come into contact with
in households, gardens, and recreational facilities like parks. This is particularly crucial
for resource-limited settings in sub-Sahara African countries, where the tropical climate
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promotes the proliferation of insects, resulting in regular exposure to other insects, such as
ants, beetles, grasshoppers, and spiders.
Studies on AMR in insects mostly focus on understanding the prevalence and potential
transfer to humans and other animals. However, given that most resistant organisms
present in insects are acquired from human-impacted environments, insects could be used
as sentinels for studying the resistome circulating within a community. The control of
insect populations is mostly carried out with insecticides that contain heavy metals, which
co-select for AMR [108–110]. A plasmid was identified in Bacillus thuringiensis, carrying
antimicrobial and insecticidal resistance genes [111]. Thus, the co-selection of insecticides
for AMR in insects requires further investigation.
Previous studies are mostly on antibiotic resistance associated with antibiotics and
bacteria. Little information exists on the potential of insects to act as reservoirs of drug-
resistant viruses and fungi. Another critical gap for establishing the risk associated with
ARB and ARGs in household insects is the lack of information regarding the transfer
efficiency of the insect bacteria to different environments (e.g., water, household surfaces,
and foods). To obtain such information, it is necessary to understand the proportion of
resistant bacteria within different insects. In addition, how long the insect would have
to be in a contaminated environment to carry a substantial number of bacteria and how
much contact time would be necessary to deposit substantial amounts of these bacteria to
different surfaces, need to be investigated further.
3.1.4. Insects as Sentinels of AMR
As insects are potential vectors of human diseases, the presence of pathogens in insects
is of importance and should be explored further. Research shows with some certainty
that insects can be a source of AMR [51]. For instance, the guts of insects are reservoirs
of AMR, especially ARGs and this AMR can be transmitted between different habitats,
including those mostly frequented by humans [51]. In particular, household insects such as
cockroaches and houseflies, which are highly associated with food animals, can potentially
facilitate the transfer of AMR between farms and urban settlements. There is research
evidence proving that these insects (cockroaches and houseflies) harbor some multiple
drug-resistant bacteria, that there is horizontal transfer of antimicrobial genes in these
insects, and that they can potentially transmit AMR from one environment to the other [38].
Additionally, several household insects such as bed bugs and fleas also harbor resistant
microorganisms containing ARGs [58,112,113]. In the gut of fleas, HGT was reported from
E. coli bacteria to Yersinia pestis, resulting in the antibiotic-resistant Y. pestis from patients in
Madagascar [112,113].
As mentioned earlier, houseflies belonging to the families Muscidae and Calliphoridae
can transmit microbial organisms, which besides bacteria also include fungi and even
viruses [74,114–118]. In addition, there is evidence that some of these transmitted microor-
ganisms are resistant to antimicrobials [119–121]. These flies normally prefer in-house
dwellings and therefore associate with humans on a large scale [122]. They use decaying
matter and excrement for laying eggs and for their nutrition [123]. Their nature, therefore,
involves the transmission of microorganisms through fecal–oral transmission [74]. Their
mobility from one habitat to the other even over quite long distances and their ability to
disseminate pathogens such as bacteria, which they carry on the surface of their exoskele-
ton and alimentary canal, supports the idea that they also spread AMR to other organisms,
including humans [93,124]. This is more so because some studies highlight the importance
of the gut of the fly in providing an excellent environment for the HGT of AMR genes and
the transport of AMR microorganisms [89,90]. In households, flies enhance the spread of
pathogens and AMR to humans, generally through food contamination, when they are in
direct contact with the food. More specifically, the transmission of AMR bacteria can be
through regurgitation, transfer from the exoskeleton, excretion, and vomiting [95].
Houseflies are suggested as good candidates to use as sentinels in the surveillance
of prevalence and spatial distribution of AMR in microbiota, such as bacteria in humans
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and animals, for several reasons. Houseflies have unrestricted movement such that they
commonly occur on or around humans and animals, are easy and cheap to catch using
simple traps, and are not subject to ethical issues, as with people [37]. These flies are also
able to access areas not easily accessible, and thus can acquire AMR organisms and their
pathogens from their diverse niches. Using a 16S rRNA-based microbial metagenomic
analysis, ARGs and MGEs detected in the tested flies were similar to those observed in
the studied sympatric animals, especially poultry feces [37]. However, robust isolation
and fingerprinting protocols are needed before flies can be deemed sentinels for AMR and
MGEs in microbiota linking to specific animals or to humans. This is because flies travel
and get in contact with a myriad of media and environments, such that it becomes difficult
to use them as sentinels of AMR for a particular population. Cockroaches were also shown
to spread ARB from swine farms and might also be used in studies to establish if they can
also be used for surveillance purposes as sentinels of antimicrobial resistance in humans
and animals. Continuous monitoring of antimicrobial resistance is vital, and the use of
easier and cheaper ways in such studies is imperative.
Just as with houseflies, cockroaches are also known to spread AMR microorganisms
such as bacteria, viruses, helminths, and protozoan, normally through food contamination
in house dwellings [125–127]. In a house, cockroaches normally occur in kitchens, food
pantries, and bathrooms and can easily move from one room to the other, in the process
carrying and transmitting microorganisms, some of which are of concern, in terms of public
health [128]. A combination of intimate interactions with human dwellings, including
stored food and contact with waste such as sewage, garbage, and other environmental
wastes, most likely impact the spread of AMR from cockroaches to humans [129]. Staphylo-
coccus aureus isolated from cockroaches sampled from houses and restaurants was shown
to exhibit AMR, and this poses a health risk as the antimicrobial-resistant S. aureus can
potentially be easily transmitted to humans from the cockroaches [130–132].
Edible insects, which form part of some human diets, also present a cause for concern
when it comes to the spread and transmission of AMR in households. Although there
is not much research done on AMR in this area, a few studies showed that some edible
insects containing different microorganisms in their guts contribute to the distribution of
ARGs [133–136]. Roughly about two billion people, mostly from Africa, Asia, and South
America, eat insects as part of their diets as they are a source of high-quality nutrition, and
evidence shows that the edible insect sector is growing swiftly [137,138]. Although several
studies showed microbiological risks associated with edible insects, as evidenced by their
insects’ microbiota [139–142], a lot still needs to be done in this regard, and it is important
to assess the safety of edible insects. However, existing evidence indicates the emergence
and spread of ARM and ARGs facilitated by edible insects to humans.
There are increased concerns with the mass breeding and continued release of geneti-
cally modified (GM) insects, such as mosquitoes and agricultural pests. As these genetically
modified insects are bred, the antibiotic tetracycline is normally added to their feed, and
overtime, these can develop AMR in their microbiota [143]. The main concern is that
when these GM insects are released to the environment, they can then potentially carry
and transmit antibiotic resistance to naturally occurring insects, in such habitats as well
as humans, which are more than often associated with such insects in their homes and
farms [143]. For example, transfer of this AMR to humans can be through ingestion of
the larvae of genetically modified mosquito in contaminated water or the ingestion of
the genetically modified pests at the larval stage, when they can normally contaminate
vegetables and fruits.
Overall, in the case of AMR in insects, previous studies mostly focused on insects of
economic interest such as agricultural insects, bees, and those insects normally associated
with pathogens of medical interest such as flies and cockroaches. Insects that do not
necessarily fit in these categories are somewhat overlooked, yet they might be significant
reservoirs, vectors, and transmitters of AMR.
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Table 1. A summary of antimicrobial resistance reported in some insects.
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3.2. Rodents
3.2.1. Rodents as Reservoirs of AMR
Besides insects and parasites [148,149], rodents such as rats, mice, and even edible
ones share the same environment with people, creating high chances of transmission
and exchange of the AMR [150]. A classic example is that of household rodents that
frequently invade peoples’ homes and therefore closely interact with humans. In instances
where small mammals such as household rodents harbor resistant microorganisms, the
transmission of these microorganisms to humans is highly probable via different pathways,
such as direct interaction, through the food chain where rodents form part of the household
diet or rodents come into direct contact with food, as well as through contact with surfaces.
This can then result in the emergence of diseases that are not easy to manage [151].
The significance of rodents, including household rodents, as a reservoir of AMR,
is inadequately recognized, with barely any large-scale research on this, as compared,
for example, to AMR in humans. However, these small mammals play a crucial role
as sentinels, reservoirs, and vectors of AMR, especially where anthropogenic factors
such as pollution are involved or in one way or the other they associate with human
waste [152–155]. Figure 3 shows the global distribution of studies reporting AMR in ro-
dents based on the literature retrieved from PubMed Central and Google Scholar databases.
Comparing Figure 3 to Figure 2 shows that fewer studies exist on AMR in rodents than
pets. In Africa, the studies on ARM in rodents are even fewer than those in insects.
In summary, microorganisms in rodents harbor genes conferring resistance to ampicillin,
penicillin, amoxicillin/clavulanic acid, tetracycline, streptomycin, co-trimoxazole, trimetho-
prim, ciprofloxacin, cefotaxime, gentamicin, apramycin, sulfamethoxazole, chlorampheni-
col, cephradine, cefuroxime, nalidixic acid, amoxicillin chloramphenicol, and orfloxacin
(Table 2). Bacteria is one of the common groups of antimicrobial-resistant pathogens har-
bored by these rodents [156–160], some of which are of serious concern to human health,
as they can be transmitted together with the AMR determinants in the shared household
environment. Examples of some bacteria species isolated from rodents include Yersinia
pestis, Salmonella Typhimurium serotype, Streptococcus moniliformis, E. coli, and Yersinia
enterocolitica, some of which were observed to be resistant to antimicrobials and yet they are
responsible for causing different types of diseases in humans [160–163]. Therefore, one can
consider rodents as multiplication foci for ARGs and are thus sources of AMR, which can
be transmitted to other organisms such as humans, in the case of household rodents [178].
Evidence from previous research showed that some rats sampled from homes as well as
within shrubs surrounding homes, exhibit AMR, making it easy for such resistance to be
transferred from the rats to humans due to interactions [178].
In other examples, rodent species such the house mouse (Mus musculus) that flourish in
urban areas including human dwellings, pose a huge health risk to other species including
humans, as they contaminate the environment with pathogenic microbes and in the process
vectoring and transmitting any form of AMR organisms that they carry. The house mouse,
commonly found indoors where it associates with humans, was reported to carry some
pathogenic organisms such as C. difficile [164], Campylobacter [165], and Salmonella [166],
which poses a huge threat if some of these bacteria exhibit AMR. A study reported multiple
AMR genes in house mice, and interestingly, the male mice exhibited more AMR genes
compared to the females [167]. This is attributable to the fact that male mice normally have
a bigger home territory compared to females, and it also increases their exposure to any
AMR microorganisms [168]. AMR in rodents is not peculiar to those that were exposed to
some form of antimicrobial agents, for example, antibiotics. In fact, it is also prevalent in
some rodent populations that were exposed to antimicrobials [159]. This suggests that in
some instances, AMR might occur naturally in some microbial populations [169,170,178].
Overall, the AMR phenomenon in rodents, among other small mammals, is compli-
cated, and the determining factors that contribute to AMR in these animals are not always
clear cut and distinct. Reports on different carriage rates of AMR in rodents, including
household rodents [154,155,171] and the several reports demonstrating that AMR in ro-
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dents is largely determined by different anthropogenic factors [154,155,172], are examples
that indicate how AMR is complicated in these animals. Given such complexity of AMR
in animals, it calls for more detailed and more specific research on the subject, to clearly
determine and understand factors that contribute to AMR in such species. Such research
can present a platform on which to base mitigation measures against AMR.
Table 2. Percentage resistance to antimicrobial agents by different bacterial species isolated from rodents.
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Figure 3. Countries (shaded) that reported AMR in rodents in the period 2010–2020. The search was based on PubMed
Central and Google Scholar databases.
3.2.2. Rodents as Vectors of AMR Transmission
The spread of AMR is facilitated through the transfer of resistant microbial organisms
between different organisms, including transfer from animals to humans or vice versa [173].
The mechanisms that control the successful transfer and transmission of resistant organisms
and their genes from rodents to humans are not very distinct and clear. However, the
intimate interactions between rodents and humans in households and farms, among
other areas, as well as their high mobility, mean rodents most likely vector and transmit
antimicrobial-resistant microorganisms to humans through contact of fecal materials and
then contamination of human food and drinking water [160,174,175,178]. For example,
invasion of agricultural land by rodents is a potential threat in the spread and transmission
of AMR to humans through contamination of livestock that is utilized by humans for food
as well as any other food contamination, such as grain that is also utilized by humans for
food [61]. The house mice have more intimate contact with humans as they have found a
niche position in structures utilized by humans, such as homes, schools, and restaurants.
This, along with other urban rodents, was proved to harbor antimicrobial-resistant bacteria
such as E. coli [156] and S. aureus [157], which can easily be transmitted to humans via—(1)
direct or close contact, and (2) contamination of utensils and food. This can be exacerbated
by non-hygienic handling of the food.
In the food chain, rodents are normally one of the initial links close to the bottom
of the chain and therefore can easily become a microbiological transmitter for several
predators, including humans. In several parts of the world, including Africa and Asia,
wild rodents form part of the traditional household diet, and if such rodents are AMR
contaminated and then ingested, this might easily become a pathway through which
AMR-resistant organisms carried by these rodents can be transmitted to humans. Wild
rodents such as riverbank voles and wood mice harbor antimicrobial-resistant bacteria (e.g.,
Enterobacteriaceae) [159], and if these form part of the household diet, such resistant bacteria
can probably be transmitted to humans through ingestion. Current concerns include AMR
transmission from rodents to humans, especially focusing on resistant microorganisms that
are known to enter the food chain, causing ease of transmission from animals to humans.
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Indirectly, rodents and even pets might harbor parasites possessing antimicrobial re-
sistance, which might be transferred to humans via such parasites. A typical example is the
emergence of antibiotic-resistant Yestinia pestis in bubonic plague patients in Madagascar,
which was linked to horizontal gene transfer from rat fleas [48]. The role of parasites in the
transfer of AMR from rodents and pets to humans and vice versa further demonstrated the
complexity of AMR. Yet, this aspect is relatively less studied compared to the direct role of
rodents and pets in the persistence and transmission of AMR.
3.2.3. Rodents as Sentinels of AMR
The capacity of rodents to act as reservoirs and vectors of AMR points to their potential
use as sentinels of AMR occurrence, transmission, and potential human health risks.
Sentinels or bioindicators are organisms with the potential to be used as an early warning
system for human health risks. A few studies showed that small animals, including
mice, voles, and insectivores, are effectively used as sentinels of antimicrobial-resistant
microorganisms and their ARGs [36,41]. In this regard, the detection of various AMR
in rodents might guide further investigations of AMR and humans and potential health
risks. Although there are several forms of AMR and ARGs, namely antibiotics resistance,
antifungal resistance, antivirals resistance, and antiparasitic resistance [29], the type of AMR
and ARGs often studied is antibiotic resistance. Several studies and reviews concerning
AMR, especially veterinary AMR, typically focus on antibiotic resistance, while excluding
other forms of antimicrobial resistance. However, this does not mean that other types of
AMR besides anti-bacterial resistance are less important, as they can potentially lead to
devastating consequences. Therefore, further work is needed to understand the potential
of other rodents, including those hunted for food. Such research should extend beyond
antibiotic resistance to include other forms of antimicrobial resistance (e.g., resistance to
antifungals, antivirals). Compared to humans, AMR in wildlife, including rodents, is
significantly less studied; hence several questions still need to be addressed pertaining to
AMR in wildlife and the implication on human health [59]. There is, therefore, an urgent
need to carry out studies that focus on the human–animal transmissions of AMR and to
clearly identify and document original sources and ranges of AMR in animals such as
rodents and the transmission pathways.
3.3. Companion Animals/Pets
3.3.1. Pets as Reservoirs of AMR
Pets or companion animals are domesticated animals normally kept within or near a
household for purposes of companionship. These include dogs, cats, rabbits, birds, horses,
rats, rabbits, guinea pigs, fish, snakes, and amphibians. Other reasons for pet ownership
include safety, exercise, and as service animals trained to carry out specific tasks for the
benefit of an individual, with a physical, mental, or sensory disability. Incidentally, owning
pets can also reduce alienation, particularly in contemporary high-tech urban societies,
which resulted in reduced human physical interaction. Medical evidence shows that pets
can improve coping with cardiovascular diseases, can reduce depression [179–181], and can
enhance child emotional and social development [182–184]. The benefits of owning pets led
to widespread and increasing pet ownership. Recent surveys showed that approximately
62% of US and 85% of European households own at least one pet [185,186].
Pets are susceptible to many diseases such as urinary tract infections, post-operative
wound infections, dental infections, and respiratory tract infections that might require
the use of antimicrobials [187–189]. Figure 4 shows the global distribution of studies on
AMR in pets based on information retrieved from PubMed Central and Google Scholar
databases. Table 3 presents common pet infections, including those resistant to antimi-
crobials. Compared to other animals, pets are more likely to be given a higher level of
healthcare because of their emotional and social proximity to their owners. This has led to
the high usage of antimicrobials to treat diseases and wounds. In turn, the widespread use
of antibiotics led to an increasing prevalence of multi-drug resistance among canine and
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cat bacterial pathogens. Susceptibility tests of bacterial isolates from UTI in dogs showed
multi-drug resistance [188,190,191]. Microorganisms in pets were reported to harbor resis-
tance to first-line and last-resort antimicrobials, including ampicillin, imipenem, colistin,
methicillin, cefotaxime, ceftazidime, cefazolin, chloramphenicol, tetracycline, doxycycline,
co-trimoxazole, cefotaxime, amoxicillin, lincomycin, enrofloxacin, ofloxacin, ciprofloxacin,
amoxicillin/clavulanic acid, erythromycin, teicoplanin, vancomycin, cephalosporin, gen-
tamycin, and tobramycin (Table 4). Some studies demonstrated that antibiotic resistance in
pets increase over time [192]. For example, in China, multidrug-resistant bacterial isolations
in China increased from 67% to 75% between 2012–2017 [193]. An even more worrying
scenario that raised public health concern is a high usage of human critically important
antibiotics (CIAs), including macrolides, (fluoro)quinolones, and 3rd and 4th generation
cephalosporins on dogs, cats, and horses [194]. A recent survey showed that CIAs were
mostly used for treating urinary tract diseases in cats (62%) and dental disease in dogs
(36%) [194]. The regular use of antibiotics increases incidences of resistance; hence, animals
that frequented treatment had more resistant S. aureus compared to healthy animals [195].
Resistance to vancomycin, an important alternative to methicillin-resistant bacteria, is
increasing. Despite vancomycin recording a very low resistance of up to 0% [196], recent
studies showed increasing vancomycin resistance as high as 24% [197]. Moreover, an-
timicrobial resistance among bacterial species that are opportunistic to humans, such as
Klebsiella and Acinetobacter spp., is an emerging human health concern [198–201].
Table 3. Some common bacterial diseases of companion animals, including those resistant to antimicrobials.
Pet Disease Causative Bacteria Reference
Dogs
Urinary tract infections, E. coli, Staphylococcus spp. (S. intermedius, S. aureus), P. aeruginosa, E. faecalis,Proteus mirabilis [202]











Bacterial pneumonia Enterobacteriaceae (e.g., E. coli, Enterobacter spp., Klebsiella spp.), Pasteurella spp.,

















In one study, all isolates of Staphylococcus spp. from ear canals (otitis externa) of pet
dogs were resistant to at least one antibiotic, while 77.1% of Staphylococcus isolates were
multi-drug-resistant [191]. The least effective antibiotics were the penicillins, ampicillin,
amoxicillin, and amoxicillin-clavulanic acid [191,210]. E. coli isolates from UTI were most
resistant to oxytetracycline and ampicillin [211]. In another study, microbial isolates from
dog UTI showed decreasing effectiveness of enrofloxacin, cephalexin, and oxytetracycline
and increasing AMR in P. aeruginosa and E. faecalis, over ten years (1999–2009) [202].
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Figure 4. Countries (shaded) that reported AMR in pets in the period 2010–2020. The search was based on PubMed Central
and Google Scholar databases.
Table 4. Some examples of antimicrobial-resistant bacterial isolates from pets in different countries. The percentage in
brackets represents the prevalence of AMR isolates where data are available.
Pet Resistance Bacteria Country Reference
Dogs, Cats Ampicillin (18%) E. coli Belgium, Italy,Netherlands [24]
Dogs Imipenem (0.2%), colistin (5%) K. pneumoniae Portugal [218]
Methicillin S. aureus [209]
Dogs, cats Cefotaxime (66–75%)Ceftazidime (71–80%) E. coli Italy [197]
Dogs Cefazolin (43%),fluoroquinolone (22%) E. coli Taiwan [219]
Dogs, Cats chloramphenicol, tetracycline, doxycycline,co-trimoxazole, ampicillin, cefotaxime Klebsiella spp. India [198]
amoxicillin (4.8%), ampicillin (21.2%), lincomycin
(98%), tetracycline (95%)_enrofloxacine(77%),
ofloxacin (64%), ciprofloxacin (73%)
Enterococcus spp.








Fluoroquinolone E. coli (40%) [220]
Carbapenem K. pneumoniae (7%) [220]
Cats
Ampicillin (42%), amoxicillin/clavulanate (53%),
erythromycin 40%), tetracycline (24%), ciprofloxacin
(63%), teicoplanin, vancomycin (24%)
E. faecium, E. faecalis Italy [197]
Horses Cephalosporin, ciprofloxacinGentamycin, tobramycin K. pneumoniae Austria [199]
Horses Several antibiotics E. coli USA [221]
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3.3.2. Pets as Vectors and Sentinels of AMR
Companion animals can transmit AMR bacteria to humans through direct contact or
indirectly in their shared environment. Pets transmit several bacterial infections to humans
via saliva, urine, feces, aerosols, and are major sources of zoonotic diseases. Some of the
common pathogens causing bacterial infections from dogs include Pasteurella, Salmonella,
Brucella, Yersinia enterocolitica, Campylobacter, Capnocytophaga, Bordetella bronchiseptica, Cox-
iella burnetii, Leptospira, Staphylococcus intermedius, and Methicillin-resistant S. aureus [212].
AMR was reported in these pathogens, pointing to the possibility for AMR transfer to
humans via pets. Humans can acquire infectious antimicrobial-resistant bacteria from
pets via (1) direct transmission of resistant bacteria to humans, or (2) the transfer of ARGs
from non-infectious bacteria (e.g., some Enterococcus spp.). The possibility of resistant
bacteria passing resistance genes to microbial flora endemic to humans has long been a
concern [213]. Although Enterococcus spp. are considered endemic bacteria to the gut
of humans and pets, they can act as reservoirs of AMR genes that can be transmitted
to pathogenic bacteria such as S. aureus and Streptococcus spp. [214]. However, there is
limited direct evidence linking AMR in pets to subsequent human exposure and health
risks. Clearly, multi-drug resistance in pets is a public health concern, and wide-ranging
and systematic mitigation measures are required (Section 5). Despite the evidence that
antibiotic usage promotes the selection of bacteria with AMR [215–217], one study reported
no association between antibiotic usage and resistance of E. coli in dogs and cats [24].
This seems to suggest that the mere use of antibiotics is not the main driver of acquired
resistance; instead, it is a result of the quality and frequency of usage.
Due to their closeness and direct contact with humans, a high risk exists for the
transmission of AMR from pets to humans (and vice-versa). Human–pet interactions also
occur via saliva, urine, feces, aerosols, and direct dermal contact, further increasing the
risk of AMR transmission. Dogs and cats are among the most studied pets, but there is
a need to understand the occurrence and potential transfer of AMR to humans via other
under-studied pet animals (e.g., birds, reptiles).
4. Human Exposure and Health Risks
4.1. Human Exposure Pathways
The identification and estimation of the adverse human health effects of AMR, in-
cluding disease incidences and outbreaks, are challenging [222]. This is partly due to a
combination of methodological limitations and the lack of essential information for deter-
mining risk. Figure 1 presents the circulation and major human exposure and transmission
pathways of antimicrobial resistance from insects, rodents, and household pets, along
with the source–pathway–receptor–impact continuum. In summary, human exposure to
AMR in rodents, insects, and pets might occur via multiple pathways—(1) direct skin or
dermal contact, especially in the case of pets (e.g., through licking of pets), and to a lesser
extent, household rodents and insects, (2) ingestion of human food including drinking
water cross-contaminated by rodents, insects, and pets harboring AMR, (3) consumption
of edible rodents and insect, and associated foods contaminated with AMR, especially
poorly cooked food, and (4) inhalation of AMR in ambient air and particulate matter con-
taminated by rodents, insects, and pets (Figure 1). Although not traced to rodents, insects,
and pets, the role of airborne transmission of AMR, and the related MGEs, transposons,
and integrons, tnpA, and intl1 is well established [15]. In turn, humans harboring AMR
originating from rodents, insects, and pets might further disseminate it into the environ-
ment, family members, and the community [223]. However, empirical evidence on the
role and relative contribution of the various pathways of human exposure to antimicrobial
resistance elements is still lacking.
To date, most review studies on general antimicrobial-resistant microorganisms and
exposure to humans overlooked the role played by flies, rodents, or household animals or
pets in transmission and risk to human health [224–226]. Dogs, as well as other sympatric
animals such as pigs and chickens, were shown to share their multidrug-resistant bacteria
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and ARGs with the studied flies and rodents in the cases of HGT [37,39,144]. For example,
using a 16S rRNA-based microbial analysis, all bacterial phyla identified in the caught flies
were also present in dogs and the other animals studied [37]. In turn, the rodents and flies
that generally live in close association with humans are most likely to transfer the ARGs
and MGEs to humans via the pathways summarized above. However, further studies
should investigate the contribution of the above-mentioned points of human exposure to
antimicrobial-resistant microorganisms and genes.
In one study, it was suspected that an antibiotic-resistant Yersinia pestis isolated from
patients in Madagascar was a result of the transmission of these bacteria through infected
fleas to humans. It was inferred that there was HGT of AMR from E. coli bacteria to Yersinia
pestis within the gut of fleas, which in turn then transmitted the antibiotic-resistant Y.
pestis to humans [52,113]. In another study, AMR was reported in bacteria isolated from
cockroaches in nursing homes and long-term care facilities in Taiwan [45]. In another study,
cockroaches, blow-flies, and houseflies were observed to be highly contaminated with hu-
man intestinal and food-borne bacterial pathogens in human homes [47,66]. These studies
did not ascertain whether or not the isolated pathogens were resistant to antimicrobials or
carried ARGs and MGEs. However, it was widely accepted in all these studies that insects
are vectors of human pathogens that cause a number of human infections worldwide when
they come into contact with food and utensils. The role of insects as vectors of foodborne
pathogens was investigated on the assumption that the presence of food-borne pathogens
in the guts and external surfaces of the flies caught in the bins of restaurants imply that
these flies are capable of carrying pathogens and contaminate food or food-re contaminate
food or food-related utensils for humans.
It can be inferred that the insects are also capable of transferring antimicrobial-resistant
pathogens, their genes, and MGEs, if present, to humans. This is because some of the identi-
fied pathogens in the above studies harbored AMR traits to several antimicrobials [40,227].
For example, stored product insects such as the red and confused flour beetles (Tribolium
castaneum, Herbst, and Tribolium confusum, Jacquelin duVal, respectively) had antibiotic-
resistant and low concentrations of virulent enterococci in their guts and were shown to
harbor MGEs, Tn916/1545 family of conjugative transposons that commonly host the ermB
and tetM genes [145]. In controlled laboratory experiments, the red flour beetle was shown
to transmit E. faecalis OG1RF—pCF10 strain with antibiotic resistance from contaminated
poultry and cattle feed to sterile feed [146]. In one of the few studies on vector–human
transmission, identical Enterobacteriaceae resistant to extended-spectrum cephalosporins
were detected in dogs from households whose owners had a rectal culture positive for
extended-spectrum cephalosporin-resistant Enterobacteriaceae [228]. Comprehensive in-
sect/household pet to human transmission studies are scarce and so are recommended to
ascertain the role of flies, rodents, and pets as vectors and sentinels of antimicrobial resis-
tance organisms, ARGs, and MGEs to humans. Such studies should also encompass strict
or controlled infection measures, given that flies, insects, and pets are mobile and traverse
varied environments from where they can carry antimicrobial-resistant microorganisms
and ARGs. Further, it is largely unknown to what extent the resistant microorganisms
occurring in the insects, rodents, or household pets studied present a risk to humans in
terms of resistance to certain antibiotics used for humans.
4.2. A Summary of the Inferential Evidence Pointing to Potential Human Health Risks
Despite the lack of strong evidence, the emergence and spread of AMR pose potential
human health risks. Multi-drug-resistant human pathogens are one of the major causes of
morbidity and mortality in patients undergoing some challenging surgeries, such as hip re-
placements and organ transplants [229,230]. AMR in humans might result in the following
adverse health outcomes—(1) treatments normally administered are rendered ineffective,
and (2) infection control becomes difficult, increasing the spread of infections and even
death, compared to infection with non-resistance pathogens. Nevertheless, human health
risks also vary due to differences in sensitivity. For example, in Zimbabwe, about 50% of
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the human immuno-deficiency virus (HIV) seropositive patients were reported to have
significantly reduced susceptibility and high-level resistance to penicillin compared to only
16% in HIV seronegative patients [231]. Babies and children are especially vulnerable given
their reckless behavior, and poor hygiene, consequently, mere landing and brief skin con-
tact with insects might result in dislodging of pathogens and associated ARGs from their
exoskeleton. However, research is scant on the effect of sensitivity in humans of varying
ages or health conditions, among other relevant factors. Besides questionnaire or interview
surveys focusing on limited factors, data on the actual human health risk posed by antimi-
crobial resistance determined using quantitative microbial risk assessment (QMRA) are still
lacking. Previous studies assumed human health risks based on exposure to risk factors
such as poor hygiene [45,232]. Farmworkers exposed to antimicrobial resistance microbiota
from livestock were infected with the antimicrobial-resistant microorganisms, as they are in
close contact with the treated animals [232,233]. In the same vein, humans in close contact
with their household pets are also likely to get infected, resulting in person-to-person
transmission of AMR. Consumption of raw or inappropriately processed foods with no
prior preservation adds to public health risk as this might harbor live bacterial cells capable
of transmitting AMR to humans. This is because food processes that kill bacteria and ARGs
in food products decrease the risk of transmission of AMR, hence reducing the gene pool
for AMR traits [225].
The occurrence of AMR in rodents and insects, including edible ones, and pets, raised
human health concerns. Yet, evidence directly linking such AMR to human exposure and
health risks remains weak. Here, selected studies pointing to potential human health risks
are summarized. For example, the antimicrobial-resistant Salmonella strain was isolated
from two rodent meat and food products (Rattus tanezumi and Bandicota indica) from Thai-
land markets [234]. However, based on the results, it was unclear if this Salmonella was
acquired from the live rodents or handling and processing of the rodent meat [234]. Evi-
dence drawn from Thailand and the Netherlands shows the existence of transferable ARGs
in specimens of edible insects (small cricket powder, small crickets, locusts, mealworm
larvae, giant waterbugs, black ants, winged termite alates, rhino beetles, mole crickets,
silkworm pupae, and black scorpions) from Thailand and Netherlands [135]. In another
study, ARGs were also reported in fresh edible insects from the Netherlands and Belgium,
particularly in crickets and mealworms [133]. Similarly, transferable ARGs were also
detected in edible grasshoppers [134].
Most edible rodents and insects reported in the literature are also widely consumed
in Africa. However, similar to other regions, the link with human health risks is still
poorly understood, highlighting the need for further research. The consumption of edible
rodents and insects is putatively high in developing regions (e.g., Africa, Asia, and South
America), especially among low-income households who cannot afford meat. Therefore,
these regions might represent ideal sites to understand the potential human exposure and
health risks associated with the consumption of edible rodents and insects with AMR.
Therefore, comprehensive studies are required to understand the occurrence of AMR in
raw or uncooked rodents and insects and the impacts of handling and culinary practices
on AMR at the point of consumption.
The lack of compelling evidence on the human exposure and health risks associated
with AMR in rodents, insects, and pets might reflect the methodological limitations of
existing studies predominantly focusing on the occurrence and characterization of AMR.
In these studies, the mere occurrence of AMR of human health concern is often interpreted
as posing human exposure and health risks. However, estimating human exposure and
health risks is a non-trial task for several reasons. First, there is a need for the accurate
quantitative determination of the likelihood or probability of the transfer of antimicrobial-
resistant organisms or resistance genes, and mobilome from the rodents, insects, and pet
reservoirs and vectors to intermediate vectors or humans. Such transfer might occur via
HGT facilitated by MGEs or via other human intake pathways, such as dermal contact,
ingestion, and inhalation. Second, there is a need to estimate the frequency and magnitude
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of human exposure to AMR in such vectors. It is important to note that not all antimicrobial-
resistant microorganisms and their resistance genes constitute human pathogens. The
antecedent human health conditions (e.g., underlying health conditions) and age might
affect human susceptibility, further complicating the estimation of human health risks.
4.3. Drought on Fertile Grounds? AMR in Insects, Rodents, and Pets in Developing Countries
Insects, rodents, and to some extent, pets are an integral component of societies in
the developing regions of Asia, South America, and Africa [7,235]. For example, both
edible insects, rodents, and other wild animals contribute significantly to household food
security and nutrition [236,237]. Companion animals, including cats and dogs, are also
common, where the latter is even used for household security and hunting edible wild
animals. Despite the prominence of these animals, AMR in insects, rodents, and pets
attracted limited research and public attention in developing countries. Yet, several risk
factors might also promote the proliferation and dissemination of AMR among the envi-
ronment, animals, and humans in developing countries. These risk factors include (1) a
putatively high number of stray animals, including dogs and cats [238]; (2) a high burden
of both animals and human diseases due to a predominantly tropical environment [10,13],
resulting in a corresponding high use, misuse and abuse of antimicrobials in animal and
human health [239]; and (3) terrestrial, aquatic and atmospheric systems highly polluted
by chemical agents including antimicrobials, pharmaceuticals, and metals that select for
antimicrobial resistance [240]. Moreover, developing countries have weak and poorly
enforced animal, human, and environmental health regulations, while early detection and
mitigation of AMR is challenging due to a lack of systematic surveillance systems [13].
Therefore, the lack of research in socio-economic settings with high-risk factors where
conditions are ideal to understand AMR in insects, rodents, and companion animals and
its health risks, is ironic. As Loewenson [241] aptly summed up, this constitutes a ‘drought
on fertile grounds’.
4.4. Towards a Quantitative Human Health Risk Assessment
Quantitative microbial risk assessment (QMRA) provides an ideal tool to overcome the
methodological limitations of current studies, while simultaneously enabling a quantitative
determination of human exposure and health risks of AMR in rodents, insects, and pets.
QMRA is a systematic approach for identifying, evaluating, and estimating the human
exposure routes and potential health risks of AMR, based on the source–exposure pathway–
receptor–impact framework [242]. QMRA uses quantitative dose-response relationships
or models to estimate human exposure pathways and the associated health risks. In the
case of AMR in rodents, insects, and pets, QMRA requires data on the following—(1)
the occurrence, nature, and concentration of various AMR in rodents, insects, and pets,
and their associated environmental media; (2) the transfer of AMR from sources such as
rodents, insects, pets, and their associated environmental media to the receptor (humans)
via multiple exposure routes (contact, ingestion, inhalation); (3) the behavior, and fate
of AMR from source to the receptor, including any degradation and potential mutations;
and (4) frequency and magnitude of human exposure via the various routes, and the
characteristics of the human receptor, including underlying conditions, age, and antecedent
health stressors. Yet currently, barring data on occurrence, the bulk of the data required
for QMRA is still lacking. Thus, estimating human exposure and health risks associated
with AMR in rodents, insects, and pets, and the development and validation of predictive
methods for risk estimation is a key area of further research. Information from such research
is critical in the development of strategies for the mitigation of potential human health
risks of AMR.
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5. Human Health Risk Assessment and Mitigation
5.1. Health Risk Assessment
Considering the risks arising from the spread of AMR, as outlined in the previous
sections, there is a need to continuously assess the associated human health risks. The
guidelines and recommendations related to the general assessment of AMR risks are
outlined elsewhere [243,244]. Thus, this part focuses specifically on AMR in insects, rodents,
and pets present in the household settings, specifically risk identification, and outlining
management goals [245].
The risk assessment of human health threats should predominantly be based on data
on the following:
• monitoring the usage of antimicrobial in companion animals,
• the extent to which the AMR occurs in pets, insects, and rodents entering households
unintentionally,
• the association between AMR in rodents, insects, and animals of interest, and humans
coming in contact with such animals, and
• the routes via which AMR microorganisms and/or ARGs can be transmitted between
household animals and humans.
Despite the knowledge on the role of livestock animals in the spread of AMR, compan-
ion animals, such as cats and dogs, were for long not regarded as a significant transmission
of ARGs or antimicrobial-resistant microorganisms to humans. Therefore, data on human
health risks traceable to AMR in insects, rodents, and pets are scarce. Hence, further
research efforts are required to generate information important for human health risk
assessment in this context. The limited understanding of the occurrence of AMR in com-
panion animals and other animals kept as pets in household settings (including rodents),
coupled with the poorly understood risk factors, and transmission routes make it difficult to
conduct comprehensive quantitative risk assessments. This position was also highlighted
by the European Medicines Agency [246]. Similarly, data to perform risk assessments
related to rodents and insects are also limited and requires further studies. To accelerate the
acquisition of data, the approach should not only be based on purely scientific studies but
must also include regularly conducted national surveillance using standardized method-
ologies. However, in the case of developing countries, such national surveillances are still
lacking. One should, however, note that investigations of AMR in companion animals and
their owners in developing countries would not be possible, without support from not only
regulatory agencies and governments but also external financial assistance.
The assessment of antimicrobial usage and AMR in cats and dogs was recently per-
formed and reported for Belgium, Italy, and The Netherlands [24]. Despite the lower use
of these pharmaceuticals compared to livestock production systems, it was concluded
that companion animals might represent a source of transmission of resistance genes or
resistant microorganisms to humans. Notably, the study revealed that among applied
antibiotics, cats and dogs frequently received CIAs. This highlights that the assessment of
human health risks must consider not only the quantity and number of pharmaceuticals in
use but also the qualitative factors (e.g., type of antimicrobials). Therefore, it is pivotal to
understand to what extent companion animals are receiving CIA as listed by the World
Health Organization [247], and the occurrence of resistance to such CIAs. This requires sys-
tematic monitoring and reporting in different geographical areas to understand the actual
proportion of microorganisms that are resistant or acquire resistance to the antimicrobial
drugs of interest.
Considering the possible transmission of AMR from companion animals to humans,
as reported in China in relation to colistin [248], it is important to understand the frequency
of AMR in pet owners relative to non-pet owners. Such assessment should also include
the collection of data on the history of antimicrobial use in both animals and humans, to
evaluate the potential correlations of AMR in the two compartments. A few studies already
exist in this regard, for example, in Brazil [249] and Denmark [250,251]. However, one
should note that correlation does not imply causation, as multiple potential routes of AMR
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transmission to humans make it difficult to determine the role of insects, rodents, and
pets. This is because, besides the history of antimicrobial use by humans, human exposure
to AMR also occurs via food (meat, eggs, milk, vegetables, and grains), drinking water,
air, and dust [243]. Therefore, more definitive conclusions on the role of rodents, insects,
and pets could only be drawn from nationwide surveillance, which is still lacking in most
countries. Although AMR increases healthcare costs, morbidity, and mortality in developed
and developing countries, its consequences for human health are of higher threat in the
latter ones. This is due to the following reasons—(1) lower quality in prescription practices,
(2) inadequate education of patients, (3) limited access to diagnostics, (4) higher rate of
unauthorized sale of antimicrobial, and (5) generally less control over the usage of these
pharmaceuticals in humans and animals [252–254].
Studies on quantitative health risk assessment should also cover the identification of
routes of AMR transmission from pets to owners, as this is pivotal to develop management
strategies and guidelines. This is, however, a particularly challenging task that should be
coupled with studies addressing the frequency of AMR in animals and humans. It is also
further complicated by the fact that there can be a bilateral transmission of AMR between
animal and owner, making the assessment of the initial source of these transmissions
even more challenging. One approach is to gather detailed information on the history of
antimicrobial use in pet owners and pets (type, dosage, time of use), level of household
hygiene, type, and frequency of intimate contacts between owner and pet, and the lifestyle
of pets (e.g., in case of cats whether it is free-ranging, or household-based and outgoing or
not). One should also note that transmission events might not only occur during the use of
antimicrobial drugs in animals, but also after the microorganisms with AMR colonize the
pet, following their excretion and contamination of households [220].
Since it is virtually impossible to conduct experimental studies directly addressing the
transmission of AMR from actual pets to their owners, some more definitive conclusions
could be drawn from prospective studies. Such research should assess the baseline level of
AMR in owner and companion animals and follow it consecutively, along with tracking the
history of antimicrobial use in both compartments. To date, no such investigations were
conducted that highlight the urgent need for such studies. The application of a similar
assessment of human health risks related to rodents and insects that are not intentionally
kept in household settings but occur temporarily, is more challenging. This is due to
difficulties in collecting the animals for material sampling, although one should note
that such investigations were conducted on small mammals (e.g., mice, shrews) outside
household settings [36].
The results indicate that rodents and insects can be sentinels or bioindicators for AMR
transmission in the environment [36]. Other studies addressing the epidemiological risks
associated with rodents entering household settings were also conducted [255–257]. This is
highly important as rodents and insects can not only acquire AMR within the household
setting but also outside from different environmental sources. These sources might not
be directly related to antibiotic usage but might also be implicated in the transmission to
companion animals, particularly outgoing cats, due to predation [36,159]. The potential
routes of transmission of AMR to humans from insects and rodents and the assessment
of frequency in which they occur, can be partially addressed via the experimental ap-
proach and use of laboratory animals. Such research should evaluate how effectively
the AMR microorganisms and genes can be transmitted during direct contact between
insects/rodents and laboratory animals, bites, contact with excrements, dead bodies, and
through consumption of edible insects, rodents, and associated human food products.
One should note that AMR is, as stated by the WHO [258], “a complex problem driven
by many interconnected factors, hence single, isolated interventions have little impact,
and coordinated actions are required”. This consideration is also consistent with the ‘One
Health’ approach. Therefore, the assessment of health risks related to household insects,
rodents, and pets, and pursuing the associated management goals can only be perceived as
an accompanying yet important element of the strategy of addressing AMR issues, risk
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assessment, and mitigation activities. At this point, such risk assessments require more
data on the frequency of AMR microorganisms in these animals, the establishment of routes
of transmission, and assessment of relation with AMR observed in humans.
5.2. Mitigation
Mitigation measures include (1) national and international guidance and monitoring
on the use of antibiotics to limit the use of CIAs and non-essential use; (2) non-clinical inter-
ventions for animal health such as good feed, pet hygiene, regular check-ups, vaccination,
and control of pests to improve animal health while reducing the use of antibiotics; (3)
training of veterinarians on the selection of appropriate therapy to reduce antimicrobial
resistance; (4) education of owners about good hygiene practices (e.g., not letting a pet to
lick owner’s face, regular hands washing); (5) raising awareness among owners to strictly
adhere to recommendations on the use of antimicrobial use (timing, dosage, etc.); and (6)
antimicrobial susceptibility testing for empirical guidance on the choice of antibiotics. For
example, soft diets in dogs and cats are associated with high incidences of dental diseases,
and harder, chewy foods requiring vigorous prehension and mastication improved dental
health [211].
Different strategies of mitigation of health risks related to AMR should be developed
for animals kept as pets and animals such as rodents and insects that enter household set-
tings temporarily. Nevertheless, the general approach should include obligatory control of
antimicrobial use and their release into the environment from all sources. In the case of pets,
represented predominantly but not exclusively by cats and dogs, the use of antimicrobials
should rely on guidelines issued to veterinary specialists and recommendations issued
to pet owners via veterinary clinics. Given the fact that there are limited antimicrobials
available for use in companion animals, the mitigation strategy should be of benefit to both
animals and humans. Specifically, such a strategy should include:
• limiting the use of antimicrobials in pets only to the clinically justified applications
• raising the awareness of the complex AMR issue within the veterinary specialists and
even among the pet owners
• limiting direct contact between pet owners and animals during the use of antimicro-
bials
• using hand hygiene practices after direct contact with pets
• avoiding intimate contacts with pets through face licking and sharing a bed
• regular cleaning of households; and
• wearing rubber, latex, or vinyl gloves when cleaning urine and droppings from insects,
rodents, and pets
In cases where rodents are not kept intentionally in household settings (predominantly
mice and rats), the following mitigation approach is proposed:
• blocking all potential entry routes (foundation cracks, unsealed windows, doors, etc.),
particularly in the colder season when the risk of entering is the highest
• sealing garbage bins and containers
• sealing food, including pet foods, to avoid cross-contamination
• cleaning the household to remove uneaten parts of food
• using traps and baits in case of a high risk of infestation; and
• preventing household cats from going outside to limit the predation, potential rodent-
cat transmission, and further cat-human transmission.
The mitigation strategy for the health risks related to AMR transmission via insects
entering the household should include:
• collection of dog’s and cat’s droppings and their appropriate disposal to avoid contact
with insects (e.g., flies) that feed or develop in excrements, acquisition of AMR and its
further spread to humans [95].
• regular cleaning of households
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• The use of preventive measures to limit insects from entering the household setting
(e.g., screens on windows, mosquito nets); and
• elimination of insects in household setting (e.g., mechanically or chemically in case of
infestations)
Given that rodents, insects, and pets might co-exist, a combination of these measures
might be required to mitigate the health risks associated with AMR.
6. Future Perspectives
6.1. Future Research Directions
Further research is needed to address several knowledge gaps in the context of the
source-pathway-receptor-impact framework.
6.1.1. Comprehensive Database on AMR in Insects, Rodents, and Companion Animals
Several insects, rodents, pets, and human ectoparasites such as lice and fleas remain
understudied [259]. Hence, there is a need for further studies, including a broad range
of common household and edible insects (ants, mosquitoes, lice, fleas, termites, moths,
crickets), and rodents and pets (e.g., birds, reptiles, rabbits, guinea pigs). Moreover,
there is a need to extend research beyond antibiotic resistance to include resistance to
antimalarials, antivirals, antihelminthics, antifungals, antiprotozoals, and antiprions [1,260].
Drug-resistance to antiprions or therapeutic drugs used to treat neurodegenerative diseases
caused by the accumulation of prions or self-propagating misfolded proteins were also
reported [1]. However, the mechanisms of some of these forms of AMR might differ from
those of antibiotic resistance.
6.1.2. Partitioning AMR between Natural and Anthropogenic Pools
The relative contribution of the intrinsic and induced AMR to the AMR burden in
insects, rodents, and pets is unclear. This is because partitioning AMR between the two
sources is difficult due to the complex behavior of AMR and methodological limitations.
Hence, research is required to develop and validate tools to partition AMR between the
two sources.
6.1.3. Transfer Mechanisms and Behavior in the Environment–Animal–Human Interface
The transfer of AMR in insects, rodents, and pets to humans might occur via multiple
pathways including contaminated food [261,262], but the exact animal–human transmission
mechanisms and behavior of AMR in each compartment remain unclear. Further work
is needed to understand the key environmental and microbial drivers of the occurrence,
proliferation, and transmission of AMR in the environment–animal–human interface. Such
evidence is critical in the development of mitigation measures to limit the circulation or
flow of AMR among the environment, animals, and humans.
6.1.4. AMR Receptors and Primers in Insects, Rodents, and Companion Animals
Cell membranes and proteins of some organisms might act as receptors or primers that
suppress or amplify AMR [263,264]. However, the existence and nature of such primers
and receptors remain poorly understood in the case of AMR in insects, rodents, and pets.
This requires further research to understand whether the differential acquisition of AMR in
various insect, rodents, and companion animal species could be attributed to such receptors
and primers. Bacteria communication or ‘quorum sensing’ is also critical in the exchange
of AMR among bacteria species and other organisms [265], but these processes are still
poorly studied in insects, rodents, and pets.
6.1.5. Insects as Potential Sources of Novel Antimicrobials to Mitigate AMR
Evidence shows that insects are a potential source of insect defensins or antimicrobial
peptides that provide the first line of defense against antimicrobials [266,267]. The capacity
of insect antimicrobial peptides as antiviral, antibacterial, and antifungal factors is reported
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in the literature [268,269]. Synthetic antimicrobial peptides or polymers are attracting
significant research attention as an alternative therapy to AMR compared to conventional
antimicrobials [270]. Thus, scope exists to develop novel antimicrobials from such insect
antimicrobial peptides, but this aspect warrants further investigation.
6.1.6. Human Exposure and Health Risks via the Consumption of Edible Insects and
Rodents
Despite harboring AMR, edible insects, rodents, birds, and other wild animals are
sources of food and nutrition in several cultures in South America, Asia, African, and even
some developed countries [7,135,271] while some insects (e.g., the Black soldier fly) are
harnessed to produce novel foods [272,273]. Several studies even show that processed
ready-to-eat insect food products derived from grasshoppers, crickets, and mealy worms
harbor AMR of human health concern [134,135,262]. However, the contribution of AMR
derived from direct consumption of edible rodents and insects and the associated food prod-
ucts is currently under-studied. Further studies focusing on regions with high consumption
of such foods are required to investigate the potential human health risks associated with
such practices.
6.1.7. Quantitative Microbial Risk Assessment
The evidence linking AMR in insects, rodents, and pets remain largely inferential and
qualitative. Further studies are required based on QMRA to determine the link between
AMR and human health risks directly. Unlike qualitative or inferential evidence, QMRA
uses quantitative dose-response models or relationships to estimate the probability of the
occurrence of an endpoint [274]. In the current case, QMRA would estimate the probability
of the occurrence of adverse human health outcomes as a result of exposure to AMR in
insects, rodents, and pets. Such QMRA should also account for the following—(1) the
nature and concentrations of the antimicrobial-resistant microorganisms and ARGs, (2)
behavior and fate of the AMR, and (3) multiple transmission pathways from source to
receptor (i.e., humans). Such research would also provide critical epidemiological evidence
linking AMR in insects, rodents, and pets to specific human health outcomes.
6.1.8. The Contribution of Insects, Rodents, and Pets to the Global Human AMR Burden
Currently, no estimates exist on the contribution of AMR in insects, rodents, and
pets to the global AMR burden and the associated health risks. As Dunachie et al. [3]
pointed out, estimating the global AMR burden in terms of morbidity and mortality is
a non-trivial task due to methodological limitations. Therefore, the development and
validation of frameworks and metrics for estimating the global contribution of AMR in
various environmental compartments or resistomes, including insects, rodents, and pets,
require further investigation.
6.1.9. Understanding the ‘Human Factor’ in AMR
Public knowledge, perceptions, attitudes, and practices as well as those of human and
animal health practitioners (i.e., the human factor) is a key driver of AMR through overuse,
misuse, and abuse of antimicrobials. However, little is known about the contribution of the
human factor to the transmission of AMR in the environment–animal–human interface.
6.1.10. Increasing the Global Footprint of Developing Regions in AMR Research
Developing regions, including Africa, are poorly represented in the literature on AMR,
particularly with respect to insects, rodents, and pets. Therefore, further research is needed
to determine the nature of AMR in various species of insect, rodent, and companion pets in
developing countries. Moreover, such research should address several generic knowledge
gaps highlighted here.
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6.2. Harnessing Emerging and Novel Tools to Unravel the Complex Behavior of AMR
The bulk of studies are based on conventional culturing and molecular techniques.
Several recent advances in analytical tools such as computational or in-silico techniques,
genomics, network analysis, and big data analytics only received a cursory application
in research on AMR in insects, rodents, and pets. Yet, these emerging tools have the
potential to complement existing conventional methods and provide further insights into
the complex behavior of AMR. The generic applications of emerging and novel analytical
tools in AMR research are discussed in an earlier paper focusing on AMR in the funeral
industry [13]. Here, potential applications of the emerging and novel tools in the context of
AMR in the environment–animal–human interface are highlighted.
6.2.1. Genomic Tools
Genomics is a collective term referring to a range of advanced molecular techniques,
including, among others, meta-transcriptomics, (exo)metabolomics, metagenomics, and
proteomics [275]. Compared to cultural methods, genomics has a number of advantages
relevant to investigating AMR in insects, rodents, and pets and their health risks. First,
genomics can be used to study the occurrence and proliferation of AMR in non-culturable
organisms in insects, rodents, pets, and humans. Moreover, genomic tools have the
capacity to reveal complex human and ecological health effects, including effects of AMR
on metabolic networks, gene expression profiling, protein and enzyme synthesis and
functions, and trophic interactions [275,276].
6.2.2. Computational or In-Silico Techniques
In-silico or computational techniques are collection modeling or simulation tools that
allow the rapid computer-aided design of virtual experiments. In the context of AMR
in the environmental–animal–human continuum, in-silico techniques have the following
potential applications—(1) rapid prototyping and analysis of complex systems including
metabolic and AMR networks, which are difficult to study via conventional research
methods, and (2) outputs of in-silico analysis can be used to inform the cost-effective
design of laboratory and field experiments, and subsequent analysis of data.
6.2.3. Network Analysis
The occurrence, dissemination, and fate of AMR in the various compartments form
a complex network that is often difficult to disentangle using conventional tools. One
question that arises is, ‘Does AMR in humans, insects, rodents, and pets originate from the same
environmental pool or resistome?’. Network analysis is a powerful tool used to understand
complex interactions among various components. Thus, a combination of network analysis
and genomics can be used to unravel such complex interactions and reveal the degrees of
similarities of AMR in the various compartments or resistomes.
6.2.4. Big Data Analytics
A comprehensive understanding of the occurrence and behavior of AMR requires
analysis of various media. These include (i) environmental media (soil, wastewaters,
drinking water, and ambient air), (ii) animals including insects, rodents, pets, and their
prey and predators, and (iii) human media such as feces, gut specimen, and serum. Such
efforts will generate large quantities of data (i.e., ‘big data’) that are often difficult to
analyze and visualize using conventional statistical tools. Big data analytics such as
machine learning might provide ideal tools for the extraction of subtle trends and patterns
in such large datasets encompassing AMR in environmental, animal, and human media
and their potential human and ecological health risks.
The application of these emerging tools could significantly improve our understanding
of the complex behavior and health risks of AMR. Research applying a combination of
these emerging tools represents the next frontier in AMR research in the environment–
animal–human continuum.
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7. Conclusions and Outlook
The present review applied the source-pathway-receptor-impact framework to track
the occurrence and circulation of AMR in household and edible insects, rodents, and
pets. Insects and rodents acquire antimicrobial resistance via foraging of prey harboring
AMR, which in turn proliferate and persist in various compartments of insects, rodents,
and pets, including the skin and gut systems. The widespread use of antimicrobial treat-
ments in veterinary medicines and pet foods also induce AMR micro-organisms found
in pets. Thus, several household insects (e.g., houseflies, cockroaches) and edible ones
(e.g., crickets, grasshoppers), rodents (rats, mice), and pets (dogs, cats), harbor and act as
reservoirs of antimicrobial resistance. To date, antimicrobial-resistant microorganisms and
their corresponding ARGs for a diverse range of first-line and last-resort antimicrobials,
including antibiotics, are reported in insects, rodents, and pets. Subsequently, household
insects, rodents, and pests act as vectors that disseminate antimicrobial resistance into
other environmental compartments, including humans via direct contact, as prey for other
organisms, human food contamination, and horizontal gene transfer. Thus, household
insects, rodents, and pets might act as sentinels or bioindicators for the surveillance of
AMR. In this regard, insects, rodents, and pets could be subsequently used as an early
warning system for the surveillance of AMR ahead of its detection in humans.
Human exposure and health risks, and key risk factors were discussed, including those
unique to low-income countries. Current evidence on human exposure and health risks
is largely inferential and qualitative. Hence, comprehensive data based on quantitative
microbial risk assessment are still lacking, making it difficult to trace specific human health
risks or outcomes to AMR in insects, rodents, and pets. To safeguard human health,
mitigation measures are proposed based on the one health approach. Future research,
including ten knowledge gaps, were highlighted, including (1) quantitative microbial risk
assessment, (2) investigating AMR in common household insects, rodents, and pets in
developing countries, (3) partitioning antimicrobial resistance in insects, rodents, and pest
between anthropogenic and natural sources, and (4) use of emerging and novel techniques
(e.g., in-silico methods, genomics, network analysis, and big data analytics or machine
learning) to understand the role of household insects, rodents, and pets in the persistence,
circulation, and health risks of AMR. These emerging tools can complement conventional
ones to address the highlighted knowledge gaps and improve our understanding of the
occurrence and circulation of AMR in the environment–animal–human continuum.
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in wild rodents—True or false threat? Pathogens 2020, 9, 771. [CrossRef]
62. Tunstall, T.; Portelli, S.; Phelan, J.; Clark, T.G.; Ascher, D.B.; Furnham, N. Combining structure and genomics to understand
antimicrobial resistance. Comput. Struct. Biotechnol. J. 2020, 18, 3377–3394. [CrossRef]
63. Lv, J.; Deng, S.; Zhang, L. A review of artificial intelligence applications for antimicrobial resistance. Biosaf. Health 2020. [CrossRef]
64. Garcia-Vidal, C.; Sanjuan, G.; Puerta-Alcalde, P.; Moreno-García, E.; Soriano, A. Artificial intelligence to support clinical
decision-making processes. EBioMedicine 2019, 46, 27–29. [CrossRef] [PubMed]
65. Smith, K.P.; Wang, H.; Durant, T.J.; Mathison, B.A.; Sharp, S.E.; Kirby, J.E.; Long, S.W.; Rhoads, D.D. Applications of artificial
intelligence in clinical microbiology diagnostic testing. Clin. Microbiol. Newsl. 2020, 42, 61–70. [CrossRef]
66. Pava-Ripoll, M.; Pearson, R.E.G.; Miller, A.K.; Ziobro, G.C. Prevalence and relative risk of Cronobacter spp., Salmonella spp., and
Listeria monocytogenes associated with the body surfaces and guts of individual filth flies. Appl. Environ. Microbiol. 2012, 78,
7891–7902. [CrossRef] [PubMed]
67. Usui, M.; Iwasa, T.; Fukuda, A.; Sato, T.; Okubo, T.; Tamura, Y. The role of flies in spreading the extended-spectrum β-lactamase
gene from cattle. Microb. Drug Resist. 2013, 19, 415–420. [CrossRef]
68. Graham, J.; Price, L.B.; Evans, S.L.; Graczyk, T.K.; Silbergeld, E.K. Antibiotic resistant enterococci and staphylococci isolated from
flies collected near confined poultry feeding operations. Sci. Total Environ. 2009, 407, 2701–2710. [CrossRef]
69. Ferri, M.; Ranucci, E.; Romagnoli, P.; Giaccone, V. Antimicrobial resistance: A global emerging threat to public health systems.
Crit. Rev. Food Sci. Nutr. 2017, 57, 2857–2876. [CrossRef]
70. Collignon, P.J.; McEwen, S.A. One health—Its importance in helping to better control antimicrobial resistance. Trop. Med. Infect.
Dis. 2019, 4, 22. [CrossRef]
71. Fukuda, A.; Usui, M.; Okubo, T.; Tagaki, C.; Sukpanyatham, N.; Tamura, Y. Co-harboring of cephalosporin (bla)/colistin (mcr)
resistance genes among Enterobacteriaceae from flies in Thailand. FEMS Microbiol. Lett. 2018, 365, 1–7. [CrossRef]
72. Sobur, A.; Haque, Z.F.; Sabuj, A.A.; Ievy, S.; Rahman, A.T.; El Zowalaty, M.E.; Rahman, T. Molecular detection of multidrug and
colistin-resistant Escherichia coli isolated from house flies in various environmental settings. Futur. Microbiol. 2019, 14, 847–858.
[CrossRef]
73. Tufa, T.B.; Fuchs, A.; Wienemann, T.; Eggers, Y.; Abdissa, S.; Schneider, M.; Jensen, B.-E.O.; Bode, J.G.; Pfeffer, K.; Häussinger,
D.; et al. Carriage of ESBL-producing Gram-negative bacteria by flies captured in a hospital and its suburban surroundings in
Ethiopia. Antimicrob. Resist. Infect. Control. 2020, 9, 175. [CrossRef] [PubMed]
74. Graczyk, T.K.; Knight, R.; Gilman, R.H.; Cranfield, M.R. The role of non-biting flies in the epidemiology of human infectious
diseases. Microbes Infect. 2001, 3, 231–235. [CrossRef]
75. Graczyk, T.K.; Cranfield, M.R.; Bixler, H.; Fayer, R. House flies (Musca domestica) as transport hosts of Cryptosporidium parvum.
Am. J. Trop. Med. Hyg. 1999, 61, 500–504. [CrossRef] [PubMed]
76. Arnold, J. Adaptive features on the tarsi of cockroaches (Insecta: Dictyoptera). Int. J. Insect Morphol. Embryol. 1974, 3, 317–334.
[CrossRef]
77. Yap, K.L.; Kalpana, M.; Lee, H.L. Wings of the common house fly (Musca domestica L.): Importance in mechanical transmission of
Vibrio cholerae. Trop. Biomed. 2008, 25, 1–8.
78. Fathpour, H.; Emtiazi, G.; Ghasemi, E. Cockroaches as reservoirs and vectors of drug resistant Salmonella spp. Fresenius Environ.
Bull. 2003, 12, 724–727.
79. Wang, H.; Sangwan, N.; Li, H.-Y.; Su, J.-Q.; Oyang, W.-Y.; Zhang, Z.-J.; Gilbert, J.A.; Zhu, Y.-G.; Ping, F.; Zhang, H.-L. The antibiotic
resistome of swine manure is significantly altered by association with the Musca domestica larvae gut microbiome. ISME J. 2017,
11, 100–111. [CrossRef]
Antibiotics 2021, 10, 68 35 of 42
80. Wang, H.; Li, H.; Gilbert, J.A.; Li, H.; Wu, L.; Liu, M.; Wang, L.; Zhou, Q.; Yuan, J.; Zhang, Z. Housefly larva vermicomposting
efficiently attenuates antibiotic resistance genes in swine manure, with concomitant bacterial population changes. Appl. Environ.
Microbiol. 2015, 81, 7668–7679. [CrossRef]
81. Fukuda, A.; Usui, M.; Okamura, M.; Dong-Liang, H.; Tamura, Y. Role of flies in the maintenance of antimicrobial resistance in
farm environments. Microb. Drug Resist. 2019, 25, 127–132. [CrossRef]
82. Nazni, W.A.; Luke, H.; Rozita, W.M.W.; Abdullah, A.G.; Sa’Diyah, I.; Azahari, A.H.; Zamree, I.; Tan, S.B.; Lee, H.L.; Sofian, M.A.
Determination of the flight range and dispersal of the house fly, Musca domestica (L.) using mark release recapture technique. Trop.
Biomed. 2005, 22, 53–61.
83. Tian, B.; Fadhil, N.H.; Powell, J.E.; Kwong, W.K.; Moran, N.A. Long-term exposure to antibiotics has caused accumulation of
resistance determinants in the gut microbiota of honeybees. mBio 2012, 3, 4–5. [CrossRef] [PubMed]
84. Ignasiak, K.; Maxwell, A. Antibiotic-resistant bacteria in the guts of insects feeding on plants: Prospects for discovering
plant-derived antibiotics. BMC Microbiol. 2017, 17, 223. [CrossRef] [PubMed]
85. Hubert, J.; Stejskal, V.; Athanassiou, C.; Throne, J.E. Health hazards associated with arthropod infestation of stored products.
Annu. Rev. Entomol. 2018, 63, 553–573. [CrossRef] [PubMed]
86. Doggett, S.L.; Dwyer, D.E.; Peñas, P.F.; Russell, R.C. Bed bugs: Clinical relevance and control options. Clin. Microbiol. Rev. 2012,
25, 164–192. [CrossRef]
87. Boiocchi, F.; Davies, M.P.; Hilton, A.C. An examination of flying insects in seven hospitals in the United Kingdom and carriage of
bacteria by true flies (Diptera: Calliphoridae, Dolichopodidae, Fanniidae, Muscidae, Phoridae, Psychodidae, Sphaeroceridae). J.
Med Entomol. 2019, 56, 1684–1697. [CrossRef]
88. Anacarso, I.; Iseppi, R.; Sabia, C.; Messi, P.; Condò, C.; Bondi, M.; De Niederhäusern, S. Conjugation-mediated transfer of
antibiotic-resistance plasmids between Enterobacteriaceae in the digestive tract of Blaberus craniifer (Blattodea: Blaberidae). J. Med
Entomol. 2016, 53, 591–597. [CrossRef]
89. Fukuda, A.; Usui, M.; Okubo, T.; Tamura, Y. Horizontal transfer of plasmid-mediated cephalosporin resistance genes in the
intestine of houseflies (Musca domestica). Microb. Drug Resist. 2016, 22, 336–341. [CrossRef]
90. Akhtar, M.; Hirt, H.; Zurek, L. Horizontal transfer of the tetracycline resistance gene tetM mediated by pCF10 among Enterococcus
faecalis in the house fly (Musca domestica L.) alimentary canal. Microb. Ecol. 2009, 58, 509–518. [CrossRef]
91. Petridis, M.; Bagdasarian, M.; Waldor, M.K.; Walker, E. Horizontal transfer of Shiga toxin and antibiotic resistance genes among
Escherichia coli strains in house fly (Diptera: Muscidae) gut. J. Med. Entomol. 2006, 43, 288–295. [CrossRef]
92. Cotton, M.; Wasserman, E.; Pieper, C.; Theron, D.; Tubbergh, D.; Campbell, G.; Fang, F.; Barnes, A.J. Invasive disease due to
extended spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal unit: The possible role of cockroaches. J. Hosp.
Infect. 2000, 44, 13–17. [CrossRef]
93. Farag, T.H.; Faruque, A.S.; Wu, Y.; Das, S.K.; Hossain, A.; Ahmed, S.; Ahmed, D.; Nasrin, D.; Kotloff, K.L.; Panchilangam, S.; et al.
Housefly population density correlates with shigellosis among children in Mirzapur, Bangladesh: A time series analysis. PLoS
Negl. Trop. Dis. 2013, 7, e2280. [CrossRef] [PubMed]
94. De Jesús, A.J.; Olsen, A.R.; Bryce, J.R.; Whiting, R.C. Quantitative contamination and transfer of Escherichia coli from foods by
houseflies, Musca domestica L. (Diptera: Muscidae). Int. J. Food Microbiol. 2004, 93, 259–262. [CrossRef] [PubMed]
95. Onwugamba, F.C.; Fitzgerald, J.R.; Rochon, K.; Guardabassi, L.; Alabi, A.; Kühne, S.; Grobusch, M.P.; Schaumburg, F. The role of
‘filth flies’ in the spread of antimicrobial resistance. Travel Med. Infect. Dis. 2018, 22, 8–17. [CrossRef] [PubMed]
96. Stoffolano, J.G. Fly foregut and transmission of microbes. Adv. Insect Physiol. 2019, 57, 27–95. [CrossRef]
97. Doud, C.W.; Zurek, L. Enterococcus faecalis OG1RF:pMV158 survives and proliferates in the house fly digestive tract. J. Med
Entomol. 2012, 49, 150–155. [CrossRef]
98. Allen, B. Excretion of viable tubercle bacilli by Blatta orientalis (the oriental cockroach) following ingestion of heat-fixed sputum
smears: A laboratory investigation. Trans. R. Soc. Trop. Med. Hyg. 1987, 81, 98–99. [CrossRef]
99. Kakumanu, M.L.; Maritz, J.M.; Carlton, J.M.; Schal, C. Overlapping community compositions of gut and fecal microbiomes in
lab-reared and field-collected german cockroaches. Appl. Environ. Microbiol. 2018, 84, e01037-18. [CrossRef]
100. Kim, T.-K.; Yong, H.I.; Kim, Y.-B.; Kim, H.-W.; Choi, Y.-S. Edible insects as a protein source: A review of public perception,
processing technology, and research trends. Food Sci. Anim. Resour. 2019, 39, 521–540. [CrossRef]
101. Levine, O.S.; Levine, M.M. Houseflies (Musca domestica) as mechanical vectors of shigellosis. Clin. Infect. Dis. 1991, 13, 688–696.
[CrossRef]
102. Kopanic, R.J.; Sheldon, B.W.; Wright, C.G. Cockroaches as vectors of salmonella: Laboratory and field trials. J. Food Prot. 1994, 57,
125–135. [CrossRef]
103. Dunbar, J.P.; Khan, N.A.; Abberton, C.L.; Brosnan, P.; Murphy, J.; Afoullouss, S.; O’Flaherty, V.; Dugon, M.M.; Boyd, A.
Synanthropic spiders, including the global invasive noble false widow Steatoda nobilis, are reservoirs for medically important and
antibiotic resistant bacteria. Sci. Rep. 2020, 10, 20916. [CrossRef] [PubMed]
104. Hyde, J.; Gorham, C.; Brackney, D.E.; Steven, B. Antibiotic resistant bacteria and commensal fungi are common and conserved in
the mosquito microbiome. PLoS ONE 2019, 14, e0218907. [CrossRef] [PubMed]
105. Lowe, C.F.; Romney, M.G. Bedbugs as vectors for drug-resistant bacteria. Emerg. Infect. Dis. 2011, 17, 1132–1134. [CrossRef]
[PubMed]
Antibiotics 2021, 10, 68 36 of 42
106. Graham, J.P.; Leibler, J.H.; Price, L.B.; Otte, J.M.; Pfeiffer, D.U.; Tiensin, T.; Silbergeld, E.K. The animal-human interface and
infectious disease in industrial food animal production: Rethinking biosecurity and biocontainment. Public Health Rep. 2008, 123,
282–299. [CrossRef] [PubMed]
107. Matilla, F.; Velleman, Y.; Harrison, W.; Nevel, M. Animal influence on water, sanitation and hygiene measures for zoonosis control
at the household level: A systematic literature review. PLoS Negl. Trop. Dis. 2018, 12, e0006619. [CrossRef]
108. Wang, C.; Yang, Y.; Wu, N.; Gao, M.; Tan, Y. Combined toxicity of pyrethroid insecticides and heavy metals: A review. Environ.
Chem. Lett. 2019, 17, 1693–1706. [CrossRef]
109. Yu, Y.; Li, X.; Yang, G.; Wang, Y.; Wang, X.; Cai, L.; Liu, X. Joint toxic effects of cadmium and four pesticides on the earthworm
(Eisenia fetida). Chemosphere 2019, 227, 489–495. [CrossRef]
110. Pu, Q.; Fan, X.-T.; Li, H.; An, X.-L.; Lassen, S.B.; Su, J.-Q. Cadmium enhances conjugative plasmid transfer to a fresh water
microbial community. Environ. Pollut. 2021, 268, 115903. [CrossRef]
111. Chelliah, R.; Park, B.-J.; Wei, S.; Park, J.-H.; Park, Y.-S.; Kim, S.-H.; Jin, Y.; Oh, D.-H. New perspectives on Mega plasmid sequence
(poh1) in Bacillus thuringiensis ATCC 10792 harbouring antimicrobial, insecticidal and antibiotic resistance genes. Microb. Pathog.
2019, 126, 14–18. [CrossRef]
112. Galimand, M.; Carniel, E.; Courvalin, P. Resistance of Yersinia pestis to antimicrobial agents. Antimicrob. Agents Chemother. 2006,
50, 3233–3236. [CrossRef]
113. Hinnebusch, B.J.; Rosso, M.-L.; Schwan, T.G.; Carniel, E. High-frequency conjugative transfer of antibiotic resistance genes to
Yersinia pestis in the flea midgut. Mol. Microbiol. 2002, 46, 349–354. [CrossRef] [PubMed]
114. Graczyk, T.K.; Knight, R.; Tamang, L. Mechanical transmission of human protozoan parasites by insects. Clin. Microbiol. Rev.
2005, 18, 128–132. [CrossRef] [PubMed]
115. Nielsen, A.A.; Skovgard, H.; Stockmarr, A.; Handberg, K.J.; Jorgensen, P.H. Persistence of low-pathogenic avian influenza
H5N7 and H7N1 subtypes in house flies (Diptera: Muscidae). J. Med. Entomol. 2011, 48, 608–614. [CrossRef] [PubMed]
116. Davari, B.; Khodavaisy, S.; Ala, F. Isolation of fungi from housefly (Musca domestica L.) at Slaughter House and Hospital in
Sanandaj, Iran. J. Prev. Med. Hyg. 2012, 53, 172–174.
117. Kassiri, H.; Zarrin, M.; Veys-Behbahani, R.; Faramarzi, S.; Kasiri, A. Isolation and identification of pathogenic filamentous fungi
and yeasts from adult house fly (Diptera: Muscidae) captured from the hospital environments in Ahvaz City, southwestern Iran.
J. Med. Entomol. 2015, 52, 1351–1356. [CrossRef]
118. Haddow, A.D.; Nasar, F.; Schellhase, C.W.; Moon, R.D.; Padilla, S.L.; Zeng, X.; Wollen, S.E.; Shamblin, J.D.; Grimes, E.C.; Zelko,
J.M.; et al. Low potential for mechanical transmission of Ebola virus via house flies (Musca domestica). Parasites Vectors 2017, 10,
218. [CrossRef]
119. Wang, J.; Ma, Z.-B.; Zeng, Z.-L.; Yang, X.-W.; Huang, Y.; Liu, J.-H. Response to comment on “The role of wildlife (wild birds) in
the global transmission of antimicrobial resistance genes”. Zool. Res. 2017, 38, 212. [CrossRef]
120. Ranjbar, R.; Izadi, M.; Hafshejani, T.T.; Khamesipour, F. Molecular detection and antimicrobial resistance of Klebsiella pneumoniae
from house flies (Musca domestica) in kitchens, farms, hospitals and slaughterhouses. J. Infect. Public Health 2016, 9, 499–505.
[CrossRef]
121. Wang, Y.-C.; Chang, Y.-C.; Chuang, H.-L.; Chiu, C.-C.; Lee, O.K.-S.; Chang, C.-C.; Hsuan, S.-L.; Lin, W.-H.; Chen, T.-H.
Transmission of Salmonella between swine farms by the housefly (Musca domestica). J. Food Prot. 2011, 74, 1012–1016. [CrossRef]
122. Olsen, A.R. Regulatory action criteria for filth and other extraneous materials. Regul. Toxicol. Pharmacol. 1998, 28, 199–211.
[CrossRef]
123. Stafford, K.C. Fly Management Handbook: A Guide to Biology, Dispersal, and Management of the House Fly and Related Flies for Farmers,
Municipalities, and Public Health Officials; The Connecticut Agricultural Experiment Station: New Haven, CT, USA, 2008.
124. Fotedar, R. Vector potential of houseflies (Musca domestica) in the transmission of Vibrio cholerae in India. Acta Trop. 2001, 78, 31–34.
[PubMed]
125. Agbodaze, D.; Owusu, S.B. Cockroaches (Periplaneta americana) as carriers of agents of bacterial diarrhoea in Accra, Ghana. Central
Afr. J. Med. 1989, 35, 484–486.
126. Fotedar, R.; Shriniwas, U.B.; Verma, A. Cockroaches (Blattella germanica) as carriers of microorganisms of medical importance in
hospitals. Epidemiology Infect. 1991, 107, 181–187. [CrossRef] [PubMed]
127. Pai, H.; Chen, W.; Peng, C. Isolation of non-tuberculous mycobacteria from hospital cockroaches (Periplaneta americana). J. Hosp.
Infect. 2003, 53, 224–228. [CrossRef]
128. Rivault, C. Spatial distribution of the cockroach, Blattella germanica, in a swimming-bath facility. Entomol. Exp. Et Appl. 1989, 53,
247–255. [CrossRef]
129. Rivault, C.; Cloarec, A.; Le Guyader, A. Bacterial contamination of food by cockroaches. J. Environ. Health 1993, 55, 21–23.
130. Islam, S.; Nath, A.D.; Islam, K.; Chakma, S.; Hossain, M.B.; Al Faruq, A.; Hassan, M.M. Isolation, identification and antimicrobial
resistance profile of Staphylococcus aureus in Cockroaches (Periplaneta americana). J. Adv. Vet. Anim. Res. 2016, 3, 221–228. [CrossRef]
131. Menasria, T.; Moussa, F.; El-Hamza, S.; Tine, S.; Megri, R.; Chenchouni, H. Bacterial load of German cockroach (Blattella germanica)
found in hospital environment. Pathog. Glob. Health 2014, 108, 141–147. [CrossRef]
132. Akinjogunla, O.J.; Odeyemi, A.; Udoinyang, E. Cockroaches (Periplaneta americana and Blattella germanica): Reservoirs of multi
drug resistant (MDR) bacteria in Uyo, Akwa Ibom State. Sci. J. Biol. Sci. 2012, 1, 19–30.
Antibiotics 2021, 10, 68 37 of 42
133. Vandeweyer, D.; Milanovic, V.; Garofalo, C.; Osimani, A.; Clementi, F.; Van Campenhout, L.; Acquilanti, L. Real-time PCR
detection and quantification of selected transferable antibiotic resistance genes in fresh edible insects from Belgium and the
Netherlands. Int. J. Food Microbiol. 2019, 290, 288–295. [CrossRef]
134. Osimani, A.; Garofalo, C.; Aquilanti, L.; Milanovic, V.; Cardinali, F.; Taccari, M.; Pasquini, M.; Tavoletti, S. Transferable antibiotic
resistances in marketed edible grasshoppers (Locusta migratoria migratorioides). J. Food Sci. 2017, 82, 1184–1192. [CrossRef]
[PubMed]
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